aldosterone has been researched along with Hyperpotassemia in 398 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aldosterone antagonists represented by nonselective spironolactone and mineralocorticoid-selective eplerenone are approved for treatment of symptomatic heart failure with reduced systolic function." | 8.87 | Aldosterone antagonists in heart failure. ( Guglin, M; Kristof-Kuteyeva, O; Novotorova, I; Pratap, P, 2011) |
| "To identify patient-specific factors associated with spironolactone-induced potassium level elevation in patients with heart failure." | 7.76 | Association of aldosterone concentration and mineralocorticoid receptor genotype with potassium response to spironolactone in patients with heart failure. ( Cavallari, LH; Dai, Y; Groo, VL; Patel, SR; Stamos, TD; Viana, MA, 2010) |
| "To report the use of fludrocortisone for heparin-induced hyperkalemia and to briefly review the available literature relating to heparin-induced hyperkalemia." | 7.70 | Fludrocortisone for the treatment of heparin-induced hyperkalemia. ( Fish, DN; Kass, CL; Sherman, DS, 2000) |
| "Clinically important hyperkalemia occurred in 2 patients receiving a single small dose of potassium chloride by mouth." | 7.67 | Hyperkalemia from single small oral doses of potassium chloride. ( Caralis, PV; Kem, DC; Oster, JR; Pelleya, R; Perez, GO, 1984) |
| "To assess the mechanism involved in hyperkalemia during angiotensin converting enzyme inhibition with captopril in chronic renal failure, captopril, 150 mg/day, was administered to 16 patients with hypertension with plasma creatinine levels between 1." | 7.67 | Inadequate aldosterone response to hyperkalemia during angiotensin converting enzyme inhibition in chronic renal failure. ( Ajzen, H; Draibe, SA; Kater, CE; Mattei, E; Zanella, MT, 1985) |
| "The effect of angiotensin converting enzyme inhibition by captopril (CAP) on serum potassium (SK) changes was studied during a three-hour glucose tolerance test (GTT) in recumbent and upright positions in 16 patients with drug-resistant hypertension." | 7.67 | Interplay of various factors in glucose-induced hyperkalemia during captopril treatment. ( Bános, C; Gercsák, G; Radó, JP, 1986) |
| "Paradoxical glucose-induced hyperkalemia (GIH) was elicited exclusively in the upright position during captopril treatment in four hypertensive patients (Group 3) without impaired glucose tolerance in three." | 7.66 | Glucose-induced hyperkalemia developing in the upright position in captopril-treated hypertensives. ( Bános, C; Csabuda, M; Gercsák, G; Molnár, Z; Pató, E; Radó, JP, 1982) |
| "A case of severe hypertension resistant to multiple drug therapy was controlled with minoxidil, captopril, and propranolol hydrochloride after treatment with these drugs alone or in other combinations had failed." | 7.66 | Interaction of minoxidil and captopril in the treatment of refractory hypertension. ( Matson, JR; Norby, LH; Robillard, JE, 1981) |
| "We noted five cases of reversible acute deterioration of renal function in patients with very mild to moderate renal insufficiency who received indomethacin for an acute gouty attack." | 7.66 | Reversible acute renal insufficiency and hyperkalemia following indomethacin therapy. ( Folkert, VW; Galler, M; Schlondorff, D, 1981) |
| "Hyporeninemic hypoaldosteronism was diagnosed in a young woman with glomerulonephritis who was receiving indomethacin therapy." | 7.66 | Indomethacin-induced prostaglandin inhibition with hyperkalemia. A reversible cause of hyporeninemic hypoaldosteronism. ( Franco, R; Mulrow, PJ; Shapiro, R; Stockard, H; Tan, SY, 1979) |
| "Spironolactone was evaluated as a diuretic in the therapy of six patients with chronic severe congestive heart failure, during which metabolic balance studies were performed." | 7.64 | EFFECT OF AN ALDOSTERONE ANTAGONIST (SPIRONOLACTONE) ON PATIENTS WITH SEVERE CONGESTIVE HEART FAILURE. ( CARRUTHERS, BM; LEDRAY, RD; MCINTOSH, HW; SERAGLIA, M; WALSH, GC, 1963) |
| "Aldosterone was in the past considered only as a prohypertensinogenic agent." | 6.46 | Aldosterone in uremia - beyond blood pressure. ( Koleganova, N; Ritz, E, 2010) |
| "Type IV renal tubular acidosis (RTA) is a syndrome of tubular dysfunction manifested clinically by persisting hyperkalemia and metabolic acidosis that occurs usually in patients with mild to moderate chronic glomerular insufficiency." | 6.37 | [Type IV renal tubular acidosis: pathogenetic role of aldosterone deficiency and hyperkalemia]. ( Schambelan, M; Sebastian, A, 1985) |
| "Concern about hyperkalemia is thought to contribute to this lack of evidence-based therapy." | 5.91 | Outcomes in patients with cardiometabolic disease who develop hyperkalemia while treated with a renin-angiotensin-aldosterone system inhibitor. ( Johnson, M; McMahon, G; Morrison, FJ; Su, M; Turchin, A, 2023) |
| "Hyperkalemia is associated with increased morbidity and mortality in patients with chronic kidney disease (CKD)." | 5.72 | Cost-Effectiveness of Treating Patients with Chronic Kidney Disease and Prior Hyperkalemia with Renin-Angiotensin-Aldosterone System Inhibitor and Patiromer: A Swiss Public Healthcare Perspective. ( Fischer, B; Serra, A; Telser, H, 2022) |
| "Salt wasting syndrome (hyponatremia, hyperkalemia, dehydration, metabolic acidosis) in early infancy could be caused by either mineralocorticoid deficiency as in congenital adrenal hyperplasia (CAH) and adrenal insufficiency or mineralocorticoid resistance as in pseudohypoaldosteronism (PHA)." | 5.46 | High aldosterone and cortisol levels in salt wasting congenital adrenal hyperplasia: a clinical conundrum. ( Boddu, SK; Madhavan, S, 2017) |
| "Hyperkalemia was defined as serum potassium >5." | 5.42 | Clinical risk factors of postoperative hyperkalemia after adrenalectomy in patients with aldosterone-producing adenoma. ( Choi, SH; Hong, AR; Kim, JH; Kim, SW; Kim, SY; Ku, EJ; Moon, MK; Park, KS; Shin, CS, 2015) |
| "Hyperkalemia is a potentially serious complication following adrenalectomy of aldosterone-producing adenomas (APA)." | 5.39 | Incidence and factors of post-adrenalectomy hyperkalemia in patients with aldosterone producing adenoma. ( Cheng, CJ; Chiang, WF; Lin, MY; Lin, SH; Sun, GH; Sung, CC; Wu, ST, 2013) |
| "Resistant hypertension has evolved as an important global health care problem." | 5.37 | What is the role of aldosterone excess in resistant hypertension and how should it be investigated and treated? ( Sica, DA, 2011) |
| "Many patients with hyperkalemia have a readily identifiable cause, which leads to appropriate management." | 5.35 | Hypothesis: a simple algorithm to distinguish between hypoaldosteronism and renal aldosterone resistance in patients with persistent hyperkalemia. ( Adam, WR, 2008) |
| "However, hyperkalemia is generally neither severe nor prolonged, in which replacement therapy with mineralocorticoid is seldom necessary." | 5.30 | A case of aldosterone-producing adenoma with severe postoperative hyperkalemia. ( Inoue, D; Koshiyama, H; Muramatsu, Y; Sasano, H; Sato, Y; Sugawa, A; Tanaka, S; Taniguchi, R; Yamauchi, M, 1998) |
| "Hyperkalemia was not caused by an adrenal disorder or acidosis and could not be abolished by interventions enhancing K clearance; saline infusions, high doses of furosemide, cortisone, cortisol, long-acting synthetic ACTH and excessive doses of aldosterone." | 5.26 | Hyperkalemia unresponsive to massive doses of aldosterone and renal tubular acidosis in a patient with chronic interstitial nephritis: clinical and experimental studies. ( Radó, JP; Szende, L; Szucs, L, 1976) |
| ""Outpatient hyperkalemia" is a new clinical syndrome in which high serum potassium levels (SK) are found in the outpatient condition returning toward normal without any specific treatment after admission to the hospital." | 5.26 | "Outpatient hyperkalemia" syndrome in renal and hypertensive patients with suppressed aldosterone production. ( Boer, P; Dorhout Mees, EJ; Rado, JP; Simatupang, T, 1979) |
| "The hyperkalemia was not caused by an adrenal disorder or acidosis and could not be abolished by diuretics, cortisone, longacting synthetic ACTH, excessive doses of DOCA and aldosterone." | 5.26 | Hyperkalemia unresponsive to massive doses of aldosterone in a patient with renal tubular acidosis. ( Radó, JP; Szende, L; Szücs, L, 1976) |
| "Aldosterone antagonists represented by nonselective spironolactone and mineralocorticoid-selective eplerenone are approved for treatment of symptomatic heart failure with reduced systolic function." | 4.87 | Aldosterone antagonists in heart failure. ( Guglin, M; Kristof-Kuteyeva, O; Novotorova, I; Pratap, P, 2011) |
| " Spironolactone and eplerenone are the mineralocorticoid receptor (MR) antagonists currently available for the treatment of hypertension." | 4.82 | Mineralocorticoid receptor antagonists and hypertension: is there a rationale? ( Gumieniak, O; Williams, GH, 2004) |
| " Digitalis and succinylcholine, by producing efflux of potassium from cells, may cause hyperkalemia." | 4.76 | Internal potassium balance and the control of the plasma potassium concentration. ( Cox, M; Feig, PU; Singer, I; Sterns, RH, 1981) |
| "To identify patient-specific factors associated with spironolactone-induced potassium level elevation in patients with heart failure." | 3.76 | Association of aldosterone concentration and mineralocorticoid receptor genotype with potassium response to spironolactone in patients with heart failure. ( Cavallari, LH; Dai, Y; Groo, VL; Patel, SR; Stamos, TD; Viana, MA, 2010) |
| " The application of fludrocortisone reversed hyperkalemia and metabolic acidosis without significant effect on MR expression." | 3.72 | Aldosterone resistance in kidney transplantation is in part induced by a down-regulation of mineralocorticoid receptor expression. ( Fehsel, K; Heering, PJ; Ivens, K; Klein-Vehne, N; Kurschat, C; Vo, DT, 2004) |
| " This abnormality, which leads to the development of hyperkalemia after the L-arginine challenge, may be related, in part, to a failure in the aldosterone response to hyperkalemia." | 3.70 | Hyperkalemia in patients infected with the human immunodeficiency virus: involvement of a systemic mechanism. ( Alcazar, JM; Bello, E; Caramelo, C; Casado, S; Fernández Guerrero, M; Gazapo, RM; Martell, N; Rovira, A; Ruilope, LM; Ruiz, E, 1999) |
| "To report the use of fludrocortisone for heparin-induced hyperkalemia and to briefly review the available literature relating to heparin-induced hyperkalemia." | 3.70 | Fludrocortisone for the treatment of heparin-induced hyperkalemia. ( Fish, DN; Kass, CL; Sherman, DS, 2000) |
| " Furosemide was administered orally because of hyperpotassemia during the period between 1 month and 7 months of age." | 3.69 | [Pseudo-Bartter syndrome without hypopotassemia: a case with unilateral multicystic dysplastic kidney and congenital contralateral hyronephrosis]. ( Fushimi, N; Hayashi, Y; Kohri, K; Kojima, Y; Mogami, T; Sasaki, S; Tsugaya, M, 1995) |
| "A 49-year-old man with liver cirrhosis and hypertension was found to have hyperkalemia out of a degree of renal insufficiency and metabolic acidosis with low to normal anion gap, aggravated by volume contraction with diarrhea and medications (captopril, spironolactone and atenolol) interfering with potassium homeostasis." | 3.68 | Hyperkalemia due to hyporeninemic hypoaldosteronism with liver cirrhosis and hypertension. ( Ahn, YH; Chang, DK; Choi, JW; Kee, CS; Kim, HJ, 1993) |
| "Clinically important hyperkalemia occurred in 2 patients receiving a single small dose of potassium chloride by mouth." | 3.67 | Hyperkalemia from single small oral doses of potassium chloride. ( Caralis, PV; Kem, DC; Oster, JR; Pelleya, R; Perez, GO, 1984) |
| "To assess the mechanism involved in hyperkalemia during angiotensin converting enzyme inhibition with captopril in chronic renal failure, captopril, 150 mg/day, was administered to 16 patients with hypertension with plasma creatinine levels between 1." | 3.67 | Inadequate aldosterone response to hyperkalemia during angiotensin converting enzyme inhibition in chronic renal failure. ( Ajzen, H; Draibe, SA; Kater, CE; Mattei, E; Zanella, MT, 1985) |
| "Hyperkalemic flaccid quadriplegia and cardiotoxic disturbances developed during antihypertensive therapy with spironolactone in a 76-year-old woman with chronic renal insufficiency." | 3.67 | Successful treatment of hyperkalemic quadriplegia associated with spironolactone. ( Radó, JP, 1988) |
| "The effect of angiotensin converting enzyme inhibition by captopril (CAP) on serum potassium (SK) changes was studied during a three-hour glucose tolerance test (GTT) in recumbent and upright positions in 16 patients with drug-resistant hypertension." | 3.67 | Interplay of various factors in glucose-induced hyperkalemia during captopril treatment. ( Bános, C; Gercsák, G; Radó, JP, 1986) |
| "To evaluate the mechanism of cyclosporine-induced hyperkalemia, the renin-angiotensin-aldosterone system and renal potassium clearance were compared in ten renal transplant recipients treated with cyclosporine and treated with azathioprine." | 3.67 | Effects of cyclosporine on the renin-angiotensin-aldosterone system and potassium excretion in renal transplant recipients. ( Bantle, JP; Ferris, TF; Najarian, JS; Nath, KA; Sutherland, DE, 1985) |
| "Paradoxical glucose-induced hyperkalemia (GIH) was elicited exclusively in the upright position during captopril treatment in four hypertensive patients (Group 3) without impaired glucose tolerance in three." | 3.66 | Glucose-induced hyperkalemia developing in the upright position in captopril-treated hypertensives. ( Bános, C; Csabuda, M; Gercsák, G; Molnár, Z; Pató, E; Radó, JP, 1982) |
| "A case of severe hypertension resistant to multiple drug therapy was controlled with minoxidil, captopril, and propranolol hydrochloride after treatment with these drugs alone or in other combinations had failed." | 3.66 | Interaction of minoxidil and captopril in the treatment of refractory hypertension. ( Matson, JR; Norby, LH; Robillard, JE, 1981) |
| "We noted five cases of reversible acute deterioration of renal function in patients with very mild to moderate renal insufficiency who received indomethacin for an acute gouty attack." | 3.66 | Reversible acute renal insufficiency and hyperkalemia following indomethacin therapy. ( Folkert, VW; Galler, M; Schlondorff, D, 1981) |
| "Hyporeninemic hypoaldosteronism was diagnosed in a young woman with glomerulonephritis who was receiving indomethacin therapy." | 3.66 | Indomethacin-induced prostaglandin inhibition with hyperkalemia. A reversible cause of hyporeninemic hypoaldosteronism. ( Franco, R; Mulrow, PJ; Shapiro, R; Stockard, H; Tan, SY, 1979) |
| "Spironolactone was evaluated as a diuretic in the therapy of six patients with chronic severe congestive heart failure, during which metabolic balance studies were performed." | 3.64 | EFFECT OF AN ALDOSTERONE ANTAGONIST (SPIRONOLACTONE) ON PATIENTS WITH SEVERE CONGESTIVE HEART FAILURE. ( CARRUTHERS, BM; LEDRAY, RD; MCINTOSH, HW; SERAGLIA, M; WALSH, GC, 1963) |
| " Therefore, we aimed to assess whether new potassium binders are effective and safe to promote medical optimization in patients with HF." | 3.01 | Safety and efficacy of new potassium binders on hyperkalemia management in patients with heart failure: a systematic review and meta-analysis of randomized controlled trials. ( Carvalho, PEP; Gewehr, DM; Lacerda, H; Nunes, MCP; Simões E Silva, AC; Tofanelli, MR; Veiga, TMA, 2023) |
| "Aldosterone measurements have been changed to the CLEIA method." | 3.01 | Recent progress in the diagnosis and treatment of primary aldosteronism. ( Shibata, H; Yoshida, Y, 2023) |
| " Adverse events occurred in 4 of 18 participants receiving AZD9977 (22." | 2.94 | Safety, Tolerability, and Pharmacokinetics of the Mineralocorticoid Receptor Modulator AZD9977 in Healthy Men: A Phase I Multiple Ascending Dose Study. ( Albayaty, M; Backlund, A; Ericsson, H; Forte, P; Greasley, PJ; Hartleib-Geschwindner, J; Heijer, M; Kjaer, M; Kragh, ÅM; Unwin, R; Wernevik, L; Whittaker, A, 2020) |
| " Spironolactone appears safe in carefully monitored maintenance hemodialysis patients, but did not affect cardiovascular parameters in this small study." | 2.90 | Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial. ( Anderson, AH; Charytan, DM; Dember, LM; DiCarli, M; Himmelfarb, J; Hsu, JY; Hung, AM; Ikizler, TA; Kimmel, PL; Kliger, AS; Landis, JR; Mehrotra, R; Raj, DS; Sharma, S; Skali, H; Weiner, DE; Williams, M, 2019) |
| "Hyperkalemia was one of the complications after primary aldosteronism surgery." | 2.82 | [Persistent and serious hyperkalemia after surgery of primary aldosteronism: A case report]. ( Cai, L; Gao, Y; Guo, XH; Wang, W; Zhang, JQ, 2022) |
| "Hyperkalemia is a common life-threatening problem in hemodialysis patients." | 2.74 | Glycyrrhetinic acid food supplementation lowers serum potassium concentration in chronic hemodialysis patients. ( Dick, B; Farese, S; Frey, BM; Frey, FJ; Kruse, A; Pasch, A; Uehlinger, DE, 2009) |
| "Aldosterone and renin were measured at the beginning and end of the study." | 2.71 | Is spironolactone safe for dialysis patients? ( Biederman, RW; Dreyfus, DE; Hussain, S; Marcus, RJ; McGill, RL, 2003) |
| " However, since haemodialysis patients are prone to hyperkalaemia, a known side effect of spironolactone, this treatment is not used in this population." | 2.71 | Safety of low-dose spironolactone administration in chronic haemodialysis patients. ( Fumeaux, Z; Mach, F; Martin, PY; Perneger, T; Rossier, M; Saudan, P; Schnetzler, B; Stoermann, C, 2003) |
| " Fifteen patients on hemodialysis receiving FCA with its dosage gradually increased from 0 to 0." | 2.70 | Potassium-lowering effect of mineralocorticoid therapy in patients undergoing hemodialysis. ( Furuya, R; Hishida, A; Kumagai, H; Maruyama, Y; Sakao, T, 2002) |
| "Captopril failed to increase PRA before furosemide, but PRA increased to 15." | 2.69 | Renin-aldosterone system can respond to furosemide in patients with hyperkalemic hyporeninism. ( Chan, R; Devita, MV; Michelis, MF; Pfaffle, AE; Sealey, JE; Swan, A; Zabetakis, PM, 1998) |
| "Aldosterone is a key risk factor promoting inflammation and fibrosis causing cardio-renal failure." | 2.66 | Mitigating risk of aldosterone in diabetic kidney disease. ( Frimodt-Møller, M; Persson, F; Rossing, P, 2020) |
| "In contrast to distal type I or classic renal tubular acidosis (RTA) that is associated with hypokalemia, hyperkalemic forms of RTA also occur usually in the setting of mild-to-moderate CKD." | 2.58 | Hyperkalemic Forms of Renal Tubular Acidosis: Clinical and Pathophysiological Aspects. ( Arruda, J; Batlle, D, 2018) |
| "Aldosterone also promotes collagen synthesis, which leads to increased arterial stiffness and elevation of blood pressure." | 2.53 | Resistant Hypertension and the Pivotal Role for Mineralocorticoid Receptor Antagonists: A Clinical Update 2016. ( Duprez, DA; Epstein, M, 2016) |
| "Aldosterone has also stimulatory effects on proton secretion that may be mediated by a non-genomic pathway." | 2.50 | Effect of mineralocorticoids on acid-base balance. ( Wagner, CA, 2014) |
| "Aldosterone was in the past considered only as a prohypertensinogenic agent." | 2.46 | Aldosterone in uremia - beyond blood pressure. ( Koleganova, N; Ritz, E, 2010) |
| "The form of renal tubular acidosis associated with hyperkalemia is usually attributable to real or apparent hypoaldosteronism." | 2.45 | Mechanisms in hyperkalemic renal tubular acidosis. ( Karet, FE, 2009) |
| "Hyporeninemic hypoaldosteronism is the mechanism causing the electrolyte disbalance reported in patients with RMND1 mutations, and can be treated." | 2.44 | Hyporeninemic hypoaldosteronism in RMND1-related mitochondrial disease. ( Beck, BB; Dijkman, H; Gracchi, V; Kömhoff, M; Monnens, L, 2024) |
| "Primary hyperaldosteronism (PHA), autonomic secretion of aldosterone by the adrenal gland, is rare." | 2.42 | [Primary hyperaldosteronism]. ( Deinum, J; van den Meiracker, AH, 2003) |
| "Renal tubular acidosis is a constellation of syndromes arising from different derangements of tubular acid transport." | 2.41 | Renal tubular acidosis syndromes. ( Kurtzman, NA, 2000) |
| "Hyperkalemia is a common feature of chronic renal insufficiency, usually ascribed to impaired K+ homeostasis." | 2.41 | Hyperkalemia: An adaptive response in chronic renal insufficiency. ( Gennari, FJ; Segal, AS, 2002) |
| "A syndrome termed hyporeninemic hypoaldosteronism, associated with hyperkalemia, has been frequently described in elderly patients." | 2.38 | Hyperkalemia in the elderly. ( Michelis, MF, 1990) |
| "Type IV renal tubular acidosis (RTA) is a syndrome of tubular dysfunction manifested clinically by persisting hyperkalemia and metabolic acidosis that occurs usually in patients with mild to moderate chronic glomerular insufficiency." | 2.37 | [Type IV renal tubular acidosis: pathogenetic role of aldosterone deficiency and hyperkalemia]. ( Schambelan, M; Sebastian, A, 1985) |
| "The syndrome is manifested by hyperchloremic metabolic acidosis often associated with hypokalemia." | 2.36 | Distal renal tubular acidosis: pathogenesis and classification. ( Batlle, D; Kurtzman, NA, 1982) |
| "Adrenalectomy for primary aldosteronism (PA) has been associated with decreased kidney function after surgery." | 1.91 | Prognostic value of contralateral suppression on kidney function after surgery in patients with primary aldosteronism. ( Andreassen, M; Clausen, C; Feltoft, CL; Hornum, M; Jepsen, JV; Krogh, J; Mørup, S; Voss, N, 2023) |
| "Concern about hyperkalemia is thought to contribute to this lack of evidence-based therapy." | 1.91 | Outcomes in patients with cardiometabolic disease who develop hyperkalemia while treated with a renin-angiotensin-aldosterone system inhibitor. ( Johnson, M; McMahon, G; Morrison, FJ; Su, M; Turchin, A, 2023) |
| "RRBP1 deficiency in mice caused hyporeninemic hypoaldosteronism, resulting in lower blood pressure, severe hyperkalemia, and sudden cardiac death." | 1.91 | ER ribosomal-binding protein 1 regulates blood pressure and potassium homeostasis by modulating intracellular renin trafficking. ( Chang, YC; Chiu, CH; Chuang, GT; Chuang, LM; Fong, SW; Hee, SW; Hsieh, ML; Hsieh, PC; Hsu, CN; Hsuan, CF; Hung, YJ; Hwu, CM; Lee, HL; Li, WY; Lin, JW; Lin, SH; Lin, SW; Lin, WC; Wu, VC; Yang, WS, 2023) |
| "Hyperkalemia is associated with increased morbidity and mortality in patients with chronic kidney disease (CKD)." | 1.72 | Cost-Effectiveness of Treating Patients with Chronic Kidney Disease and Prior Hyperkalemia with Renin-Angiotensin-Aldosterone System Inhibitor and Patiromer: A Swiss Public Healthcare Perspective. ( Fischer, B; Serra, A; Telser, H, 2022) |
| "Hypoaldosteronism was isolated in the majority of cases: only 6/112 (5%) had primary adrenal insufficiency." | 1.72 | Clinical manifestations and associated factors in acquired hypoaldosteronism in endocrinological practice. ( Calle-Pascual, AL; De Miguel Novoa, MP; Gómez-Hoyos, E; Rubio-Herrera, MÁ; Ruiz-Sánchez, JG; Runkle, I, 2022) |
| "Pseudohypoaldosteronism type I is a rare genetic disease of mineralocorticoid resistance that typically manifests in neonatal age." | 1.56 | Failure to Thrive, Hyponatremia, Hyperkalemia - Differential Diagnostic Reflections of a Rare Genetic Disease. ( de Potzolli, B; Seeliger, S; Tropschuh, A, 2020) |
| "Salt wasting syndrome (hyponatremia, hyperkalemia, dehydration, metabolic acidosis) in early infancy could be caused by either mineralocorticoid deficiency as in congenital adrenal hyperplasia (CAH) and adrenal insufficiency or mineralocorticoid resistance as in pseudohypoaldosteronism (PHA)." | 1.46 | High aldosterone and cortisol levels in salt wasting congenital adrenal hyperplasia: a clinical conundrum. ( Boddu, SK; Madhavan, S, 2017) |
| "We describe the clinical course of renal tubular acidosis (RTA) type 4 in pregnancy, which has not been previously published." | 1.43 | Renal tubular acidosis type 4 in pregnancy. ( Baynes, K; Jakes, AD; Nelson-Piercy, C, 2016) |
| "Hyperkalemia was defined as serum potassium >5." | 1.42 | Clinical risk factors of postoperative hyperkalemia after adrenalectomy in patients with aldosterone-producing adenoma. ( Choi, SH; Hong, AR; Kim, JH; Kim, SW; Kim, SY; Ku, EJ; Moon, MK; Park, KS; Shin, CS, 2015) |
| "Sensitivity and specificity were calculated for clinical prediction score of ≥5 points." | 1.40 | A clinical prediction score for diagnosing unilateral primary aldosteronism may not be generalizable. ( Dias, VC; Harvey, A; Kline, GA; Pasieka, JL; So, B; Venos, ES, 2014) |
| "Hyperkalemia is a potentially serious complication following adrenalectomy of aldosterone-producing adenomas (APA)." | 1.39 | Incidence and factors of post-adrenalectomy hyperkalemia in patients with aldosterone producing adenoma. ( Cheng, CJ; Chiang, WF; Lin, MY; Lin, SH; Sun, GH; Sung, CC; Wu, ST, 2013) |
| "Resistant hypertension has evolved as an important global health care problem." | 1.37 | What is the role of aldosterone excess in resistant hypertension and how should it be investigated and treated? ( Sica, DA, 2011) |
| "Many patients with hyperkalemia have a readily identifiable cause, which leads to appropriate management." | 1.35 | Hypothesis: a simple algorithm to distinguish between hypoaldosteronism and renal aldosterone resistance in patients with persistent hyperkalemia. ( Adam, WR, 2008) |
| "Hyporeninaemic hypoaldosteronism is managed with a low potassium diet and a low dose loop or thiazide diuretic." | 1.35 | Persistent hyperkalaemia. ( Murray, M; Xu, B, 2009) |
| "Primary aldosteronism is the most common form of mineralocorticoid hypertension." | 1.33 | [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases]. ( Dabasi, G; Füto, L; Gláz, E; Horányi, J; Jakab, C; Járay, J; Kiss, R; Major, L; Molnár, F; Patócs, A; Perner, F; Rácz, K; Szücs, N; Tóth, M; Tulassay, Z; Varga, I, 2006) |
| "Hyperkalemia is widely viewed as a common complication of ACE inhibition in azotemic patients." | 1.31 | Hyperkalemia, renal failure, and converting-enzyme inhibition: an overrated connection. ( Baigorria, ST; García, NH; Juncos, LI, 2001) |
| "Drug-induced hyperkalemia is an important but often overlooked problem encountered commonly in clinical practice." | 1.30 | University of Miami Division of Clinical Pharmacology therapeutic rounds: drug-induced hyperkalemia. ( Hirsh MJ, MD; Oster HR, MD; Oster, MD; Preston, RA, 1998) |
| "However, hyperkalemia is generally neither severe nor prolonged, in which replacement therapy with mineralocorticoid is seldom necessary." | 1.30 | A case of aldosterone-producing adenoma with severe postoperative hyperkalemia. ( Inoue, D; Koshiyama, H; Muramatsu, Y; Sasano, H; Sato, Y; Sugawa, A; Tanaka, S; Taniguchi, R; Yamauchi, M, 1998) |
| "In adults, persistent hyperkalemic distal renal tubular acidosis in the absence of impaired renal function is an unusual abnormality usually associated with the syndromes of aldosterone deficiency or resistance." | 1.29 | Pseudohypoaldosteronism with normal blood pressure. ( Laxdal, V; Morris, G; Shoker, A; Skomro, R, 1996) |
| "Twenty-eight patients with primary aldosteronism were treated from 1974 to 1990." | 1.28 | [Diagnosis and treatment of primary aldosteronism]. ( Wang, GY, 1992) |
| " This study shows the threshold dosage of UFH leading to suppression of mineralocorticoid metabolism in man and provides information that LMWH as well as UFH can suppress mineralocorticoid production." | 1.28 | Dose dependent suppression of mineralocorticoid metabolism by different heparin fractions. ( Andrassy, K; Back, T; Nawroth, P; Seelig, HP; Siebels, M; Vecsei, P; Weber, E, 1992) |
| "Hyperkalemia is a frequent complication in very low birth weight infants." | 1.28 | Hyperkalemia in very low birth weight infants. ( Hayen, LK; Kilbride, HW; Meade, VM; Shaffer, SG; Warady, BA, 1992) |
| "Heparin-induced hypoaldosteronism leading to hyperkalemia is an uncommon adverse effect." | 1.28 | Heparin-induced hyperkalemia. ( Aull, L; Chao, H; Coy, K, 1990) |
| "Hyperkalemia has been implicated in the pathogenesis of metabolic acidosis in chronic renal insufficiency because acidosis is ameliorated after administration of medications that correct hyperkalemia: mineralocorticoids, diuretics, intestinal K+-binding agents." | 1.27 | Amelioration of metabolic acidosis by dietary potassium restriction in hyperkalemic patients with chronic renal insufficiency. ( Hulter, HN; Jones, JW; Kurtz, I; Maher, T; Schambelan, M; Sebastian, A, 1984) |
| "The hyperkalemia was disproportionate to the degree of renal excretory impairment." | 1.27 | Hyporeninemic hypoaldosteronism in two patients with systemic lupus erythematosus. ( Kiley, J; Zager, P, 1984) |
| "Type IV Renal tubular acidosis (RTA) is a syndrome whose physiopathological and clinical peculiarities have been described in the last decade." | 1.27 | [Physiopathology and clinical aspects of type IV renal tubular acidosis]. ( Caimi, G; D'Asaro, S; Lo Presti, R, 1987) |
| "Hyperkalemia has been noted to occur spontaneously in patients with long-standing systemic lupus erythematosus who did not have advanced renal insufficiency." | 1.27 | Systemic lupus erythematosus presenting with hyporeninemic hypoaldosteronism in a 10-year-old girl. ( Bansal, VK; Fresco, R; Hano, JE; Hurley, RM; Kozeny, GA; Vertuno, LL, 1986) |
| "The pathogenesis of acquired hypoaldosteronism, a frequent cause of hyperkalemia in patients with chronic renal failure, is poorly understood." | 1.27 | Effect of dopaminergic blockade on plasma aldosterone in acquired hypoaldosteronism. ( Chusid, P; Hoeldtke, RD; Krishna, GG, 1987) |
| "The acidosis and hyperkalemia are corrected by hydrochlorothiazide." | 1.27 | Familiar hyperkalaemic acidosis. ( Amundson, D; Hsueh, WA; Licht, JH; Lombardo, JV, 1985) |
| "This hyperkalemia was due to hypoaldosteronism caused by inadequate hormone biosynthesis in the absence of 21-hydroxylase." | 1.26 | [21-hydroxylase deficit revealed by hyperkalemia in the absence of renal failure in an insulin-dependent diabetic (author's transl)]. ( Colin, JY; Conessa, JM; Godeau, P; Raux-Eurin, MG; Wechsler, B, 1981) |
| "Amiloride 5 to 10 mg was given orally for 6 wk." | 1.26 | Effects of amiloride on oral glucose loading, serum potassium, renin, and aldosterone in diet-controlled diabetes. ( Affrime, MB; Gould, A; Lowenthal, DT; Mazzella, J; Onesti, G; Shirk, J; Walker, F, 1980) |
| "The hyperkalemia was corrected by fluorocortisone administration." | 1.26 | [Hyporeninemic hypoaldosteronism. Case report and attempt at pathophysiological classification (author's transl)]. ( Barbadillo García de Velasco, R; Cuervas-Mons, V; Lorenz Pérez, P; Martín Jiménez, T; Martín Martín, F; Moya Mir, MS; Sánchez Miró, I, 1980) |
| "2%) during superimposed chronic administration of superphysiologic doses of mineralocorticoid hormone." | 1.26 | Mineralocorticoid-resistant renal hyperkalemia without salt wasting (type II pseudohypoaldosteronism): role of increased renal chloride reabsorption. ( Rector, FC; Schambelan, M; Sebastian, A, 1981) |
| "Three patients had sickle cell anemia, two had sickle cell trait and one had S-C disease." | 1.26 | Hyperkalemic hyperchloremic metabolic acidosis in sickle cell hemoglobinopathies. ( Arruda, JA; Batlle, D; Itsarayoungyuen, K; Kurtzman, NA, 1982) |
| "Acetazolamide was given to 11 patients but failed to increase fractional potassium excretion to normal." | 1.26 | Hyperkalemic distal renal tubular acidosis associated with obstructive uropathy. ( Arruda, JA; Batlle, DC; Kurtzman, NA, 1981) |
| "Hyperkalemia was not caused by an adrenal disorder or acidosis and could not be abolished by interventions enhancing K clearance; saline infusions, high doses of furosemide, cortisone, cortisol, long-acting synthetic ACTH and excessive doses of aldosterone." | 1.26 | Hyperkalemia unresponsive to massive doses of aldosterone and renal tubular acidosis in a patient with chronic interstitial nephritis: clinical and experimental studies. ( Radó, JP; Szende, L; Szucs, L, 1976) |
| ""Outpatient hyperkalemia" is a new clinical syndrome in which high serum potassium levels (SK) are found in the outpatient condition returning toward normal without any specific treatment after admission to the hospital." | 1.26 | "Outpatient hyperkalemia" syndrome in renal and hypertensive patients with suppressed aldosterone production. ( Boer, P; Dorhout Mees, EJ; Rado, JP; Simatupang, T, 1979) |
| "Two patients with long-standing systemic lupus erythematosus were found to have persistent hyperkalemia." | 1.26 | Impaired renal tubular potassium secretion in systemic lupus erythematosus. ( Agus, ZS; Cooke, CR; Cox, M; DeFronzo, RA; Goldberg, M; Myers, AR, 1977) |
| "The hyperkalemia was not caused by an adrenal disorder or acidosis and could not be abolished by diuretics, cortisone, longacting synthetic ACTH, excessive doses of DOCA and aldosterone." | 1.26 | Hyperkalemia unresponsive to massive doses of aldosterone in a patient with renal tubular acidosis. ( Radó, JP; Szende, L; Szücs, L, 1976) |
| "Hypokalemic hypertension is the leading symptome of the disease." | 1.26 | [Primary aldosteronism]. ( Beckerhoff, R; Braun, KP; Furrer, J; Nussberger, J; Pouliadis, G; Siegenthaler, W; Sobbe, A; Vetter, H; Vetter, W; Witassek, F, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 232 (58.29) | 18.7374 |
| 1990's | 45 (11.31) | 18.2507 |
| 2000's | 38 (9.55) | 29.6817 |
| 2010's | 46 (11.56) | 24.3611 |
| 2020's | 37 (9.30) | 2.80 |
| Authors | Studies |
|---|---|
| Fischer, B | 1 |
| Serra, A | 1 |
| Telser, H | 1 |
| Wang, W | 1 |
| Cai, L | 1 |
| Gao, Y | 1 |
| Guo, XH | 1 |
| Zhang, JQ | 1 |
| Palmer, BF | 3 |
| Clegg, DJ | 1 |
| Kovacs, J | 1 |
| Talib, S | 1 |
| Khashan, A | 1 |
| Garsondiya, B | 1 |
| Carson, MP | 1 |
| Coelho Almeida, A | 1 |
| Bastos Gomes, M | 1 |
| Martins, SA | 1 |
| Marques, OP | 1 |
| Gomes, MM | 1 |
| Antunes, AM | 1 |
| Epstein, M | 5 |
| Kovesdy, CP | 1 |
| Clase, CM | 1 |
| Sood, MM | 1 |
| Pecoits-Filho, R | 1 |
| Leon, SJ | 1 |
| Tangri, N | 1 |
| Voss, N | 1 |
| Mørup, S | 1 |
| Clausen, C | 1 |
| Feltoft, CL | 1 |
| Jepsen, JV | 1 |
| Hornum, M | 1 |
| Andreassen, M | 1 |
| Krogh, J | 1 |
| Szmigielska, A | 1 |
| Ruiz-Sánchez, JG | 1 |
| Calle-Pascual, AL | 1 |
| Rubio-Herrera, MÁ | 1 |
| De Miguel Novoa, MP | 1 |
| Gómez-Hoyos, E | 1 |
| Runkle, I | 1 |
| Johnson, M | 1 |
| Morrison, FJ | 1 |
| McMahon, G | 1 |
| Su, M | 1 |
| Turchin, A | 1 |
| Kanda, E | 1 |
| Rastogi, A | 1 |
| Murohara, T | 1 |
| Lesén, E | 1 |
| Agiro, A | 3 |
| Arnold, M | 1 |
| Chen, G | 1 |
| Yajima, T | 1 |
| Järbrink, K | 1 |
| Pollack, CV | 1 |
| Chiu, CH | 1 |
| Hsuan, CF | 1 |
| Lin, SH | 3 |
| Hung, YJ | 1 |
| Hwu, CM | 1 |
| Hee, SW | 1 |
| Lin, SW | 1 |
| Fong, SW | 1 |
| Hsieh, PC | 1 |
| Yang, WS | 1 |
| Lin, WC | 1 |
| Lee, HL | 1 |
| Hsieh, ML | 1 |
| Li, WY | 1 |
| Lin, JW | 1 |
| Hsu, CN | 1 |
| Wu, VC | 1 |
| Chuang, GT | 1 |
| Chang, YC | 1 |
| Chuang, LM | 1 |
| Asakawa, M | 1 |
| Takagi, N | 1 |
| Hamada, D | 1 |
| Yamasaki, Y | 1 |
| Takaku, Y | 1 |
| Kawada, M | 1 |
| Murata, T | 1 |
| Katsuta, H | 1 |
| Ward, T | 1 |
| Lewis, RD | 1 |
| Brown, T | 1 |
| Baxter, G | 1 |
| de Arellano, AR | 1 |
| Cañas, AE | 1 |
| Troutt, HR | 1 |
| Jiang, L | 1 |
| Tonthat, S | 1 |
| Darwish, O | 1 |
| Ferrey, A | 1 |
| Lotfipour, S | 1 |
| Kalantar-Zadeh, K | 1 |
| Hanna, R | 1 |
| Lau, WL | 1 |
| Carvalho, PEP | 1 |
| Veiga, TMA | 1 |
| Lacerda, H | 1 |
| Tofanelli, MR | 1 |
| Gewehr, DM | 1 |
| Nunes, MCP | 1 |
| Simões E Silva, AC | 1 |
| Yoshida, Y | 1 |
| Shibata, H | 1 |
| An, J | 1 |
| Zhou, H | 1 |
| Ni, L | 1 |
| Harrision, TN | 1 |
| Wei, R | 1 |
| Brahmbhatt, YG | 1 |
| Oluwatosin, Y | 2 |
| Schilling, CG | 1 |
| Sim, JJ | 1 |
| Berber, M | 1 |
| Leng, S | 1 |
| Wengi, A | 1 |
| Winter, DV | 1 |
| Odermatt, A | 1 |
| Beuschlein, F | 1 |
| Loffing, J | 1 |
| Breault, DT | 1 |
| Penton, D | 1 |
| Wada, N | 1 |
| Baba, S | 1 |
| Sugawara, H | 1 |
| Miyoshi, A | 1 |
| Obara, S | 1 |
| Kömhoff, M | 1 |
| Gracchi, V | 1 |
| Dijkman, H | 1 |
| Beck, BB | 1 |
| Monnens, L | 1 |
| Dwyer, JP | 1 |
| Desai, P | 1 |
| Chinnadurai, R | 1 |
| Rengarajan, S | 1 |
| Budden, JJ | 1 |
| Quinn, CM | 1 |
| Kalra, PA | 1 |
| Whittaker, A | 1 |
| Kragh, ÅM | 1 |
| Hartleib-Geschwindner, J | 1 |
| Albayaty, M | 1 |
| Backlund, A | 1 |
| Greasley, PJ | 1 |
| Heijer, M | 1 |
| Kjaer, M | 1 |
| Forte, P | 1 |
| Unwin, R | 1 |
| Wernevik, L | 1 |
| Ericsson, H | 1 |
| Frimodt-Møller, M | 1 |
| Persson, F | 1 |
| Rossing, P | 1 |
| Wetmore, JB | 1 |
| Yan, H | 1 |
| Horne, L | 1 |
| Peng, Y | 1 |
| Gilbertson, DT | 1 |
| Zeng, ZP | 1 |
| Tropschuh, A | 1 |
| de Potzolli, B | 1 |
| Seeliger, S | 1 |
| Üsküdar Cansu, D | 1 |
| Cansu, GB | 1 |
| Güvenir, S | 1 |
| Korkmaz, C | 1 |
| Rossignol, P | 1 |
| Lainscak, M | 1 |
| Crespo-Leiro, MG | 1 |
| Laroche, C | 1 |
| Piepoli, MF | 1 |
| Filippatos, G | 1 |
| Rosano, GMC | 1 |
| Savarese, G | 1 |
| Anker, SD | 1 |
| Seferovic, PM | 1 |
| Ruschitzka, F | 1 |
| Coats, AJS | 1 |
| Mebazaa, A | 1 |
| McDonagh, T | 1 |
| Sahuquillo, A | 1 |
| Penco, M | 1 |
| Maggioni, AP | 1 |
| Lund, LH | 2 |
| Chan, EY | 1 |
| Ma, AL | 1 |
| Tullus, K | 1 |
| Moriyama, H | 1 |
| Kohno, T | 1 |
| Kohsaka, S | 1 |
| Faingelernt, Y | 1 |
| Hershkovitz, E | 1 |
| Abu-Libdeh, B | 1 |
| Abedrabbo, A | 1 |
| Abu-Rmaileh Amro, S | 1 |
| Zarivach, R | 1 |
| Zangen, D | 1 |
| Lavi, E | 1 |
| Haim, A | 1 |
| Parvari, R | 1 |
| Abu-Libdeh, A | 1 |
| Volterrani, M | 2 |
| Perrone, V | 2 |
| Sangiorgi, D | 1 |
| Giacomini, E | 1 |
| Iellamo, F | 1 |
| Degli Esposti, L | 2 |
| Bolaños, JA | 1 |
| Seliger, SL | 1 |
| Boddu, SK | 1 |
| Madhavan, S | 1 |
| Shariq, OA | 1 |
| Bancos, I | 1 |
| Cronin, PA | 1 |
| Farley, DR | 1 |
| Richards, ML | 1 |
| Thompson, GB | 1 |
| Young, WF | 1 |
| McKenzie, TJ | 1 |
| Pitt, B | 1 |
| Santoro, A | 1 |
| Mandreoli, M | 1 |
| Cooper, LB | 1 |
| Hernandez, AF | 1 |
| Batlle, D | 3 |
| Arruda, J | 1 |
| Charytan, DM | 1 |
| Himmelfarb, J | 1 |
| Ikizler, TA | 1 |
| Raj, DS | 1 |
| Hsu, JY | 1 |
| Landis, JR | 1 |
| Anderson, AH | 1 |
| Hung, AM | 1 |
| Mehrotra, R | 1 |
| Sharma, S | 1 |
| Weiner, DE | 1 |
| Williams, M | 1 |
| DiCarli, M | 1 |
| Skali, H | 1 |
| Kimmel, PL | 1 |
| Kliger, AS | 1 |
| Dember, LM | 1 |
| Korkut, S | 1 |
| Akin, L | 2 |
| Hatipoglu, N | 1 |
| Özdemir, A | 1 |
| Gündüz, Z | 1 |
| Dursun, I | 2 |
| Korkmaz, L | 1 |
| Kurtoglu, S | 2 |
| Lytvyn, Y | 1 |
| Godoy, LC | 1 |
| Scholtes, RA | 1 |
| van Raalte, DH | 1 |
| Cherney, DZ | 1 |
| Atmis, B | 1 |
| Turan, İ | 1 |
| Melek, E | 1 |
| Bayazit, AK | 1 |
| Farfel, Z | 4 |
| Mayan, H | 2 |
| Karlish, SJD | 1 |
| Sopfe, J | 1 |
| Simmons, JH | 1 |
| Chiang, WF | 1 |
| Cheng, CJ | 1 |
| Wu, ST | 1 |
| Sun, GH | 1 |
| Lin, MY | 1 |
| Sung, CC | 2 |
| van der Lubbe, N | 2 |
| Moes, AD | 1 |
| Rosenbaek, LL | 1 |
| Schoep, S | 1 |
| Meima, ME | 1 |
| Danser, AH | 1 |
| Fenton, RA | 1 |
| Zietse, R | 2 |
| Hoorn, EJ | 2 |
| Vitzthum, H | 1 |
| Seniuk, A | 1 |
| Schulte, LH | 1 |
| Müller, ML | 1 |
| Hetz, H | 1 |
| Ehmke, H | 1 |
| Van Buren, PN | 1 |
| Adams-Huet, B | 1 |
| Nguyen, M | 1 |
| Molina, C | 1 |
| Toto, RD | 2 |
| Tamargo, J | 1 |
| Solini, A | 1 |
| Ruilope, LM | 3 |
| Bauersachs, J | 2 |
| Jaisser, F | 1 |
| Toto, R | 1 |
| Wagner, CA | 1 |
| Venos, ES | 1 |
| So, B | 1 |
| Dias, VC | 1 |
| Harvey, A | 1 |
| Pasieka, JL | 1 |
| Kline, GA | 1 |
| Schwenk, MH | 1 |
| Hirsch, JS | 1 |
| Bomback, AS | 1 |
| Park, KS | 1 |
| Kim, JH | 1 |
| Ku, EJ | 1 |
| Hong, AR | 1 |
| Moon, MK | 1 |
| Choi, SH | 1 |
| Shin, CS | 1 |
| Kim, SW | 1 |
| Kim, SY | 1 |
| Liu, CC | 1 |
| Lin, CM | 1 |
| Duprez, DA | 1 |
| Jakes, AD | 1 |
| Baynes, K | 1 |
| Nelson-Piercy, C | 1 |
| Rodan, AR | 1 |
| Weir, MR | 1 |
| Bakris, GL | 1 |
| Gross, C | 1 |
| Mayo, MR | 1 |
| Garza, D | 1 |
| Stasiv, Y | 1 |
| Yuan, J | 1 |
| Berman, L | 1 |
| Williams, GH | 4 |
| Xu, C | 1 |
| Lu, A | 1 |
| Wang, H | 1 |
| Fang, H | 1 |
| Zhou, L | 1 |
| Sun, P | 1 |
| Yang, T | 1 |
| Emmett, M | 1 |
| Mehta, A | 1 |
| Adam, WR | 1 |
| Karet, FE | 1 |
| Xu, B | 1 |
| Murray, M | 1 |
| Vallon, V | 1 |
| Schroth, J | 1 |
| Lang, F | 1 |
| Kuhl, D | 1 |
| Uchida, S | 2 |
| Farese, S | 1 |
| Kruse, A | 1 |
| Pasch, A | 1 |
| Dick, B | 1 |
| Frey, BM | 1 |
| Uehlinger, DE | 1 |
| Frey, FJ | 1 |
| Schweiger, B | 1 |
| Moriarty, MW | 1 |
| Cadnapaphornchai, MA | 1 |
| Bogdanović, R | 1 |
| Stajić, N | 1 |
| Putnik, J | 1 |
| Paripović, A | 1 |
| Cavallari, LH | 1 |
| Groo, VL | 1 |
| Viana, MA | 1 |
| Dai, Y | 1 |
| Patel, SR | 1 |
| Stamos, TD | 1 |
| Ritz, E | 1 |
| Koleganova, N | 1 |
| Inada, M | 1 |
| Iwasaki, K | 1 |
| Imai, C | 1 |
| Hashimoto, S | 1 |
| Poggio, R | 1 |
| Grancelli, HO | 1 |
| Miriuka, SG | 1 |
| Kendirci, M | 1 |
| Akin, MA | 1 |
| Hartmann, MF | 1 |
| Wudy, SA | 1 |
| Pichler, RH | 1 |
| de Boer, IH | 1 |
| Formosa, M | 1 |
| Webb, NJ | 1 |
| Shenoy, M | 1 |
| Guglin, M | 1 |
| Kristof-Kuteyeva, O | 1 |
| Novotorova, I | 1 |
| Pratap, P | 1 |
| Kaneko, K | 1 |
| Manikam, L | 1 |
| Cornes, MP | 1 |
| Kalra, D | 1 |
| Ford, C | 1 |
| Gama, R | 1 |
| Boccanelli, A | 1 |
| Agostoni, P | 1 |
| Sica, DA | 1 |
| Shavit, L | 1 |
| Lifschitz, MD | 1 |
| Galuppo, P | 1 |
| Furuya, R | 1 |
| Kumagai, H | 1 |
| Sakao, T | 1 |
| Maruyama, Y | 1 |
| Hishida, A | 1 |
| Puhto, M | 1 |
| Maruyama, K | 1 |
| Watanabe, H | 1 |
| Onigata, K | 1 |
| van den Meiracker, AH | 1 |
| Deinum, J | 1 |
| HUDSON, JB | 1 |
| CHOBANIAN, AV | 1 |
| RELMAN, AS | 1 |
| LAMBREW, CT | 1 |
| CARVER, ST | 1 |
| PETERSON, RE | 1 |
| HORWITH, M | 1 |
| MANNING, RT | 1 |
| BEHRLE, FC | 1 |
| DAVIS, JO | 3 |
| URQUHART, J | 1 |
| HIGGINS, JT | 1 |
| MCARDLE, B | 1 |
| CARRUTHERS, BM | 1 |
| LEDRAY, RD | 1 |
| SERAGLIA, M | 1 |
| MCINTOSH, HW | 1 |
| WALSH, GC | 1 |
| MERTENS, HG | 2 |
| SCHIMRIGK, K | 1 |
| VOLKWEIN, U | 1 |
| VOIGT, KD | 1 |
| MIROUZE, J | 1 |
| CIURANA, A | 1 |
| WILSON, ID | 1 |
| GOETZ, FC | 1 |
| RIVADENEYRA, J | 1 |
| ULICK, S | 2 |
| GAUTIER, E | 1 |
| VETTER, KK | 1 |
| MARKELLO, JR | 1 |
| YAFFE, S | 1 |
| LOWE, CU | 1 |
| VISSER, HK | 2 |
| COST, WS | 2 |
| LELOUP-HATEY, J | 1 |
| Hussain, S | 1 |
| Dreyfus, DE | 1 |
| Marcus, RJ | 1 |
| Biederman, RW | 1 |
| McGill, RL | 1 |
| Saudan, P | 1 |
| Mach, F | 1 |
| Perneger, T | 1 |
| Schnetzler, B | 1 |
| Stoermann, C | 1 |
| Fumeaux, Z | 1 |
| Rossier, M | 1 |
| Martin, PY | 1 |
| Heering, PJ | 1 |
| Kurschat, C | 1 |
| Vo, DT | 1 |
| Klein-Vehne, N | 1 |
| Fehsel, K | 1 |
| Ivens, K | 1 |
| Koren-Michowitz, M | 1 |
| Avni, B | 1 |
| Michowitz, Y | 1 |
| Moravski, G | 1 |
| Efrati, S | 1 |
| Golik, A | 1 |
| White, PC | 1 |
| Martin, R | 1 |
| Arrizurieta de Muchnik, E | 1 |
| Gumieniak, O | 1 |
| McMurray, JJ | 1 |
| O'Meara, E | 1 |
| Struthers, AD | 1 |
| Lam, Q | 1 |
| Schneider, HG | 1 |
| Szücs, N | 1 |
| Gláz, E | 1 |
| Varga, I | 1 |
| Tóth, M | 1 |
| Kiss, R | 1 |
| Patócs, A | 1 |
| Jakab, C | 1 |
| Perner, F | 1 |
| Járay, J | 1 |
| Horányi, J | 1 |
| Dabasi, G | 1 |
| Molnár, F | 1 |
| Major, L | 1 |
| Füto, L | 1 |
| Rácz, K | 1 |
| Tulassay, Z | 1 |
| Kaname, S | 1 |
| Takeda, Y | 1 |
| Funder, JW | 1 |
| Proctor, G | 1 |
| Linas, S | 1 |
| Ring, AM | 1 |
| Cheng, SX | 1 |
| Leng, Q | 1 |
| Kahle, KT | 1 |
| Rinehart, J | 1 |
| Lalioti, MD | 1 |
| Volkman, HM | 1 |
| Wilson, FH | 1 |
| Hebert, SC | 1 |
| Lifton, RP | 1 |
| Henrotte, JG | 1 |
| Bacq, ZM | 1 |
| Klaus, D | 2 |
| Lederle, RM | 1 |
| Vecsei, P | 2 |
| Rosa, RM | 2 |
| Silva, P | 1 |
| Young, JB | 1 |
| Landsberg, L | 1 |
| Brown, RS | 3 |
| Rowe, JW | 1 |
| Epstein, FH | 3 |
| Massara, F | 2 |
| Martelli, S | 1 |
| Cagliero, E | 2 |
| Camanni, F | 1 |
| Molinatti, GM | 2 |
| Mantero, F | 1 |
| Rosenberg, S | 1 |
| Franks, RC | 1 |
| Phelps, KR | 2 |
| Oh, MS | 2 |
| Carroll, HJ | 2 |
| Hahn, JA | 1 |
| Zipser, RD | 1 |
| Barg, A | 1 |
| Stone, RA | 1 |
| Zia, PK | 1 |
| Hsueh, WA | 3 |
| Horton, R | 3 |
| Sterns, RH | 2 |
| Cox, M | 4 |
| Feig, PU | 1 |
| Singer, I | 5 |
| Hiatt, N | 1 |
| Chapman, LW | 1 |
| Davidson, MB | 1 |
| Sheinkopf, JA | 1 |
| Mack, H | 1 |
| Low, J | 1 |
| Sawicki, G | 1 |
| Textor, SC | 1 |
| Bravo, EL | 1 |
| Fouad, FM | 1 |
| Tarazi, RC | 1 |
| Han, ML | 1 |
| Hsieh, BS | 1 |
| Chen, WY | 1 |
| Yen, TS | 1 |
| Chen, FW | 1 |
| Chang, CC | 1 |
| Paladini, G | 1 |
| Bertolini, L | 1 |
| Picco, S | 1 |
| Sgoifo, E | 1 |
| Maher, T | 1 |
| Schambelan, M | 6 |
| Kurtz, I | 1 |
| Hulter, HN | 2 |
| Jones, JW | 2 |
| Sebastian, A | 7 |
| Batlle, DC | 5 |
| Kurtzman, NA | 8 |
| Hené, RJ | 1 |
| Koomans, HA | 1 |
| Boer, P | 6 |
| Roos, JC | 1 |
| Dorhout Mees, EJ | 3 |
| Large, DM | 1 |
| Carr, PH | 1 |
| Laing, I | 1 |
| Davies, M | 1 |
| Kiley, J | 1 |
| Zager, P | 1 |
| Mehta, BR | 1 |
| Cavallo, T | 1 |
| Remmers, AR | 1 |
| DuBose, TD | 4 |
| Yang, CS | 1 |
| Lee, SH | 1 |
| Hung, SS | 1 |
| Dumić, M | 1 |
| Mardesić, D | 1 |
| Plavsić, V | 1 |
| Brkljacić, L | 1 |
| Novak, M | 1 |
| Pal, D | 1 |
| Kastelan, A | 1 |
| Radó, JP | 19 |
| Brohee, D | 1 |
| Neve, P | 1 |
| Merkt, J | 1 |
| Perez, GO | 8 |
| Oster, JR | 9 |
| Pelleya, R | 2 |
| Caralis, PV | 1 |
| Kem, DC | 1 |
| Rastogi, SP | 1 |
| Crawford, C | 1 |
| Wheeler, R | 1 |
| Flanigan, W | 1 |
| Arruda, JA | 5 |
| Yoshino, M | 1 |
| Amerian, R | 1 |
| Brautbar, N | 2 |
| Stalnikowicz, R | 2 |
| Shalev, O | 1 |
| Rosenmann, E | 1 |
| Ben-Ishay, D | 1 |
| Bános, C | 2 |
| Gercsák, G | 2 |
| Molnár, Z | 1 |
| Pató, E | 1 |
| Csabuda, M | 1 |
| Weidmann, P | 5 |
| Sehy, JT | 1 |
| Roseman, MK | 1 |
| Baronowski, RL | 1 |
| Takeda, R | 2 |
| Miyamori, I | 2 |
| Takimoto, H | 1 |
| Honjo, A | 1 |
| Morise, T | 1 |
| Yasuhara, S | 1 |
| Koshida, H | 1 |
| Takeda, J | 1 |
| Ikeda, M | 1 |
| Morimoto, S | 1 |
| Fujimura, A | 1 |
| Wechsler, B | 1 |
| Colin, JY | 1 |
| Raux-Eurin, MG | 1 |
| Conessa, JM | 1 |
| Godeau, P | 1 |
| Lieberman, RL | 1 |
| Lowenthal, DT | 1 |
| Gould, A | 1 |
| Shirk, J | 1 |
| Mazzella, J | 1 |
| Affrime, MB | 1 |
| Walker, F | 1 |
| Onesti, G | 1 |
| DeFronzo, RA | 5 |
| Biglieri, EG | 2 |
| Kutyrina, IM | 1 |
| Androsova, SO | 1 |
| Tormey, WP | 1 |
| Morgan, DB | 2 |
| Hahn, J | 1 |
| Zipser, R | 1 |
| Zia, P | 1 |
| Tuck, M | 1 |
| Golub, M | 1 |
| Warren, SE | 1 |
| O'Connor, DT | 1 |
| Dillon, MJ | 1 |
| Leonard, JV | 1 |
| Buckler, JM | 1 |
| Ogilvie, D | 1 |
| Lillystone, D | 1 |
| Honour, JW | 1 |
| Shackleton, CH | 2 |
| Cuervas-Mons, V | 1 |
| Moya Mir, MS | 1 |
| Martín Martín, F | 1 |
| Barbadillo García de Velasco, R | 1 |
| Sánchez Miró, I | 1 |
| Martín Jiménez, T | 1 |
| Lorenz Pérez, P | 1 |
| Tan, SY | 2 |
| Burton, M | 1 |
| Sunderlin, FS | 1 |
| Anderson, GH | 1 |
| Streeten, DH | 1 |
| Blumenthal, SA | 1 |
| Matson, JR | 1 |
| Norby, LH | 1 |
| Robillard, JE | 1 |
| Goldszer, RC | 1 |
| Coodley, EL | 1 |
| Rosner, MJ | 1 |
| Simons, WM | 1 |
| Schwartz, AB | 1 |
| Galler, M | 1 |
| Folkert, VW | 1 |
| Schlondorff, D | 1 |
| Khristov, V | 1 |
| Barratt, LJ | 2 |
| Leehey, D | 1 |
| Gantt, C | 1 |
| Lim, V | 1 |
| Rector, FC | 1 |
| Saruta, T | 3 |
| Nagahama, S | 1 |
| Eguchi, T | 1 |
| Oka, M | 1 |
| Kanbegawa, A | 1 |
| Itsarayoungyuen, K | 1 |
| Graber, AL | 1 |
| Bia, M | 2 |
| Smith, D | 1 |
| Bannister, KM | 1 |
| Knobel, B | 1 |
| Robson, M | 1 |
| Fryd, CH | 1 |
| Saidel, I | 1 |
| Kelijman, M | 1 |
| Nonoguchi, H | 1 |
| Miyagawa, H | 1 |
| Shinohara, S | 1 |
| Ida, T | 1 |
| Tomida, K | 1 |
| Kokot, F | 1 |
| Bodziony, D | 1 |
| Garnacho de Vega, A | 1 |
| Romero González, R | 1 |
| Rey, C | 1 |
| Nobili, B | 1 |
| Iolascon, A | 1 |
| Pinto, L | 1 |
| Scarano, G | 1 |
| Reineck, HJ | 1 |
| Bisbocci, D | 1 |
| Passarino, G | 1 |
| Carta, Q | 1 |
| Nicolis, GL | 1 |
| Kahn, T | 1 |
| Sanchez, A | 1 |
| Gabrilove, JL | 1 |
| Fishman, LM | 2 |
| Tsugaya, M | 1 |
| Hayashi, Y | 1 |
| Sasaki, S | 1 |
| Kojima, Y | 1 |
| Kohri, K | 1 |
| Mogami, T | 1 |
| Fushimi, N | 1 |
| Muhammad, S | 1 |
| Mamish, ZM | 1 |
| Tucci, JR | 1 |
| Schlueter, W | 2 |
| Keilani, T | 2 |
| Kee, CS | 1 |
| Choi, JW | 1 |
| Chang, DK | 1 |
| Ahn, YH | 1 |
| Kim, HJ | 3 |
| Gruessner, RW | 1 |
| Gores, PF | 1 |
| Matas, AJ | 1 |
| Allon, M | 1 |
| Allen, DB | 1 |
| Krapf, R | 1 |
| Clark, BA | 2 |
| Shannon, C | 1 |
| Gervino, EV | 1 |
| Shoker, A | 1 |
| Morris, G | 1 |
| Skomro, R | 1 |
| Laxdal, V | 1 |
| Radó, J | 2 |
| Tóth, A | 1 |
| Haris, A | 1 |
| Hottelart, C | 1 |
| Achard, JM | 1 |
| Moriniere, P | 1 |
| Zoghbi, F | 1 |
| Dieval, J | 1 |
| Fournier, A | 1 |
| Chan, R | 1 |
| Sealey, JE | 1 |
| Michelis, MF | 2 |
| Swan, A | 1 |
| Pfaffle, AE | 1 |
| Devita, MV | 1 |
| Zabetakis, PM | 1 |
| Shustin, L | 1 |
| Wald, H | 1 |
| Popovtzer, MM | 2 |
| McDonald, FJ | 1 |
| Yang, B | 1 |
| Hrstka, RF | 1 |
| Drummond, HA | 1 |
| Tarr, DE | 1 |
| McCray, PB | 1 |
| Stokes, JB | 1 |
| Welsh, MJ | 1 |
| Williamson, RA | 1 |
| Andersson, HC | 1 |
| Frentz, J | 1 |
| Martínez, JE | 1 |
| Tuck-Muller, CM | 1 |
| Bellizaire, J | 1 |
| Preston, RA | 1 |
| Hirsh MJ, MD | 1 |
| Oster, MD | 1 |
| Oster HR, MD | 1 |
| Shah, SM | 1 |
| Bavdekar, MS | 1 |
| Lokeshwar, MR | 1 |
| Shah, BV | 1 |
| Kudoh, A | 1 |
| Sakai, T | 1 |
| Ishihara, H | 1 |
| Matsuki, A | 1 |
| Taniguchi, R | 1 |
| Koshiyama, H | 1 |
| Yamauchi, M | 1 |
| Tanaka, S | 1 |
| Inoue, D | 1 |
| Sato, Y | 1 |
| Sugawa, A | 1 |
| Muramatsu, Y | 1 |
| Sasano, H | 1 |
| Caramelo, C | 1 |
| Bello, E | 1 |
| Ruiz, E | 1 |
| Rovira, A | 1 |
| Gazapo, RM | 1 |
| Alcazar, JM | 2 |
| Martell, N | 1 |
| Casado, S | 1 |
| Fernández Guerrero, M | 1 |
| Przedlacki, J | 1 |
| Debowska, M | 1 |
| Matuszkiewicz-Rowińska, J | 1 |
| Janik, P | 1 |
| Sherman, DS | 1 |
| Kass, CL | 1 |
| Fish, DN | 1 |
| Lenaerts, A | 1 |
| Codden, T | 1 |
| Henry, JP | 1 |
| Van Cauter, J | 1 |
| Meunier, JC | 1 |
| Ligny, G | 1 |
| Achermann, JC | 1 |
| Ito, M | 1 |
| Silverman, BL | 1 |
| Habiby, RL | 1 |
| Pang, S | 1 |
| Rosler, A | 5 |
| Jameson, JL | 1 |
| Kantor, R | 1 |
| García, NH | 1 |
| Baigorria, ST | 1 |
| Juncos, LI | 1 |
| Schaafsma, IA | 1 |
| van Emst, MG | 1 |
| Kooistra, HS | 1 |
| Verkleij, CB | 1 |
| Peeters, ME | 1 |
| Rijnberk, A | 1 |
| Everts, ME | 1 |
| Nowicki, M | 1 |
| Miszczak-Kuban, J | 1 |
| Gennari, FJ | 1 |
| Segal, AS | 1 |
| Szylman, P | 1 |
| Better, OS | 1 |
| Chaimowitz, C | 1 |
| Ilnicki, LP | 1 |
| Harbottle, JA | 1 |
| Morris, RC | 1 |
| Nascimento, L | 1 |
| Kumar, SK | 1 |
| Gonzalez, JJ | 1 |
| Werk, EE | 2 |
| Thrasher, K | 1 |
| Behar, R | 1 |
| Loadholt, CB | 1 |
| deLeiva, A | 1 |
| Christlieb, AR | 1 |
| Melby, JC | 1 |
| Graham, CA | 1 |
| Day, RP | 1 |
| Luetscher, JA | 1 |
| Zager, PG | 1 |
| Szende, L | 3 |
| Szucs, L | 2 |
| Arora, KK | 1 |
| Pfeifer, MA | 1 |
| Wolter, C | 1 |
| Melo, J | 1 |
| Samols, E | 1 |
| Benoit, G | 1 |
| Simatupang, T | 3 |
| Goldberg, M | 4 |
| Cooke, CR | 2 |
| Barker, C | 1 |
| Grossman, RA | 1 |
| Agus, ZS | 2 |
| Roll, D | 1 |
| Licht, A | 1 |
| Durst, AL | 1 |
| Kleeman, CR | 3 |
| Czaczkes, JW | 1 |
| Heim, J | 2 |
| Knochel, JP | 2 |
| Mees, EJ | 1 |
| Shapiro, R | 1 |
| Franco, R | 1 |
| Stockard, H | 1 |
| Mulrow, PJ | 1 |
| Wintour, EM | 1 |
| Marelyn, E | 1 |
| Barnes, A | 1 |
| Cahill, F | 1 |
| Hardy, KJ | 1 |
| Horacek, I | 1 |
| Scoggins, BA | 1 |
| Beroniade, V | 1 |
| Cornielle, L | 1 |
| Haraoui, B | 1 |
| MacCarthy, EP | 1 |
| Stokes, GS | 2 |
| Lee, MR | 1 |
| Ball, SG | 1 |
| Thomas, TH | 1 |
| Brezis, M | 1 |
| Litvin, Y | 1 |
| Caron, C | 1 |
| Nawar, T | 1 |
| Montambault, P | 1 |
| Plante, GE | 1 |
| Kandalaft, N | 1 |
| Dewailly, P | 1 |
| Jaillard, J | 1 |
| Levi, J | 2 |
| Leitesdorf, E | 1 |
| Djaldeti, M | 1 |
| Ammon, RA | 1 |
| May, WS | 1 |
| Nightingale, SD | 1 |
| Iida, K | 1 |
| Shirai, D | 1 |
| Fukuhara, Y | 1 |
| Barbour, GL | 1 |
| Keller, AW | 1 |
| Iaina, A | 2 |
| Rosenthal, T | 1 |
| Waks, U | 1 |
| Shibolet, S | 1 |
| Gafni, J | 2 |
| Goldfarb, S | 2 |
| Vaamonde, CA | 4 |
| Myers, AR | 1 |
| Lespier, L | 1 |
| Jacobi, J | 1 |
| Katz, FH | 2 |
| Sherwin, RS | 1 |
| Felig, P | 1 |
| Degli Esposti, A | 1 |
| Ambrosioni, G | 1 |
| Zaniboni, MG | 1 |
| Anand, SK | 1 |
| Froberg, L | 1 |
| Northway, JD | 1 |
| Weinberger, M | 1 |
| Wright, JC | 1 |
| Rosen, MS | 1 |
| Strunk, B | 1 |
| Krehl, WA | 1 |
| Priest, JN | 1 |
| Ahmed, M | 1 |
| Nuttall, FQ | 1 |
| Vetter, W | 1 |
| Vetter, H | 1 |
| Nussberger, J | 1 |
| Witassek, F | 1 |
| Beckerhoff, R | 1 |
| Pouliadis, G | 1 |
| Braun, KP | 1 |
| Sobbe, A | 1 |
| Furrer, J | 1 |
| Siegenthaler, W | 1 |
| Hirszel, P | 1 |
| Wang, GY | 1 |
| Siebels, M | 1 |
| Andrassy, K | 1 |
| Seelig, HP | 1 |
| Back, T | 1 |
| Nawroth, P | 1 |
| Weber, E | 1 |
| Hizon, M | 1 |
| Kaplan, B | 1 |
| Bae, HY | 1 |
| Isenring, P | 1 |
| Lebel, M | 1 |
| Grose, JH | 1 |
| Eisenstein, B | 1 |
| Davidovitz, M | 1 |
| Garty, BZ | 1 |
| Shmueli, D | 1 |
| Ussim, A | 1 |
| Stark, H | 1 |
| Spital, A | 1 |
| Picco, P | 1 |
| Garibaldi, L | 1 |
| Cotellessa, M | 1 |
| DiRocco, M | 1 |
| Borrone, C | 1 |
| Shaffer, SG | 1 |
| Kilbride, HW | 1 |
| Hayen, LK | 1 |
| Meade, VM | 1 |
| Warady, BA | 1 |
| Klemm, SA | 3 |
| Gordon, RD | 6 |
| Tunny, TJ | 3 |
| Thompson, RE | 1 |
| Wakabayashi, Y | 1 |
| Hirsch, DJ | 1 |
| Terzi, F | 1 |
| Assael, BM | 2 |
| Claris-Appiani, A | 1 |
| Marra, G | 2 |
| Dell'Agnola, CA | 1 |
| Tadini, B | 1 |
| Tomaselli, V | 1 |
| Braithwaite, SS | 1 |
| Barbato, AL | 1 |
| Emanuele, MA | 1 |
| Aull, L | 1 |
| Chao, H | 1 |
| Coy, K | 1 |
| Finn, WL | 1 |
| Kleinfeld, M | 1 |
| Corcoran, AJ | 1 |
| Soppi, E | 1 |
| Viikari, J | 1 |
| Seppälä, P | 1 |
| Lehtonen, A | 1 |
| Saarinen, R | 1 |
| Miilunpalo, S | 1 |
| D'Asaro, S | 1 |
| Lo Presti, R | 1 |
| Caimi, G | 1 |
| Butenandt, I | 1 |
| Dörr, HG | 1 |
| Kuhnle, U | 2 |
| Bosson, D | 1 |
| Mees, N | 1 |
| Ramet, J | 1 |
| Vamos, E | 1 |
| Vertongen, F | 1 |
| Wolter, R | 1 |
| Armanini, D | 1 |
| Ader, JL | 2 |
| Waeber, B | 1 |
| Suc, JM | 2 |
| Brunner, HR | 1 |
| Tran-Van, T | 2 |
| Durand, D | 2 |
| Praddaude, F | 1 |
| Ravenscroft, PJ | 1 |
| Hamlet, SM | 1 |
| Kokko, JP | 1 |
| Zanella, MT | 1 |
| Mattei, E | 1 |
| Draibe, SA | 1 |
| Kater, CE | 1 |
| Ajzen, H | 1 |
| Kinouchi, T | 1 |
| Hasegawa, M | 1 |
| Shimizu, N | 1 |
| Speiser, PW | 1 |
| Stoner, E | 1 |
| New, MI | 1 |
| Findling, JW | 1 |
| Adams, AH | 1 |
| Raff, H | 1 |
| Blumberg, A | 1 |
| Shaw, S | 1 |
| Gnädinger, M | 1 |
| Caflisch, CR | 1 |
| Rey, JP | 1 |
| Lloveras, JJ | 1 |
| Bernadet, P | 1 |
| Lee, FO | 2 |
| Quismorio, FP | 1 |
| Troum, OM | 1 |
| Anderson, PW | 1 |
| Do, YS | 1 |
| Smoller, S | 1 |
| Rashid, K | 1 |
| Välimäki, M | 1 |
| Kauppinen-Mäkelin, R | 1 |
| Pelkonen, R | 1 |
| Sauder, SE | 1 |
| Kelch, RP | 1 |
| Grekin, RJ | 1 |
| Kelsch, RC | 1 |
| Williams, ME | 1 |
| Nadler, JL | 1 |
| Hsueh, W | 1 |
| Rocher, LL | 1 |
| Tannen, RL | 1 |
| Kaufman, JS | 1 |
| Peck, M | 1 |
| Hamburger, RJ | 1 |
| Flamenbaum, W | 2 |
| Yoshida, S | 1 |
| Sakura, H | 1 |
| Takaichi, K | 1 |
| Yamashita, N | 1 |
| Kurokawa, K | 1 |
| Ogata, E | 1 |
| Travis, PS | 1 |
| Cushner, HM | 1 |
| Werder, EA | 1 |
| Hilbe, W | 1 |
| Vallotton, MB | 1 |
| Kozeny, GA | 2 |
| Hurley, RM | 2 |
| Fresco, R | 1 |
| Vertuno, LL | 2 |
| Bansal, VK | 2 |
| Hano, JE | 2 |
| Diamond, TH | 1 |
| Huddle, KR | 1 |
| Dubb, A | 1 |
| Leor, R | 1 |
| Claris Appiani, A | 1 |
| Tirelli, SA | 1 |
| Goj, V | 1 |
| Romeo, L | 1 |
| Cavanna, G | 1 |
| Zeller, WP | 1 |
| Krishna, GG | 1 |
| Chusid, P | 1 |
| Hoeldtke, RD | 1 |
| Nahum, H | 2 |
| Paillard, M | 2 |
| Prigent, A | 2 |
| Leviel, F | 2 |
| Bichara, M | 2 |
| Gardin, JP | 2 |
| Idatte, JM | 2 |
| Bantle, JP | 1 |
| Nath, KA | 1 |
| Sutherland, DE | 1 |
| Najarian, JS | 1 |
| Ferris, TF | 1 |
| Licht, JH | 1 |
| Amundson, D | 1 |
| Lombardo, JV | 1 |
| May, ME | 1 |
| Lim-Abrahan, MA | 1 |
| Brown, I | 1 |
| Garber, AJ | 1 |
| Kitaoka, T | 1 |
| Takahashi, K | 1 |
| Akisawa, T | 1 |
| Koshikawa, S | 1 |
| Ashouri, OS | 1 |
| Nieto, J | 1 |
| Gutiérrez Millet, V | 1 |
| Gutiérrez Rodero, F | 1 |
| Miranda, B | 1 |
| Bello, I | 1 |
| Rodicio, JL | 1 |
| Theodor, R | 1 |
| Gazit, E | 1 |
| Biochis, H | 1 |
| Rabinowitz, D | 1 |
| Kenny, FM | 1 |
| Reynolds, JW | 1 |
| Green, OC | 1 |
| David, R | 1 |
| Golan, S | 1 |
| Drucker, W | 1 |
| Gerstein, AR | 1 |
| Gold, EM | 1 |
| Franklin, SS | 1 |
| Maxwell, MH | 4 |
| Gonick, HC | 1 |
| Feffer, ML | 1 |
| Steinman, TI | 1 |
| Lurati, M | 1 |
| Führ, J | 1 |
| Veyrat, R | 1 |
| Muller, AF | 1 |
| Mach, RS | 1 |
| Perez, G | 1 |
| Siegel, L | 1 |
| Schreiner, GE | 1 |
| Taylor, AA | 2 |
| Johnson, JA | 1 |
| Stockigt, JR | 1 |
| Brown, JJ | 1 |
| Chinn, RH | 1 |
| Fraser, R | 1 |
| Lever, AF | 1 |
| Morton, JJ | 1 |
| Robertson, JI | 1 |
| Tree, M | 1 |
| Waite, MA | 1 |
| Park, DM | 1 |
| Reinhart, R | 1 |
| Rowe, P | 2 |
| Coburn, JW | 1 |
| Massry, SG | 1 |
| Healy, JK | 1 |
| Elliott, AJ | 1 |
| Harrison, LC | 1 |
| Werning, C | 1 |
| Snodgrass, GH | 1 |
| Krötlinger, M | 1 |
| Winer, R | 1 |
| Bursztein, S | 1 |
| de Lima, J | 1 |
| Kosman, ME | 1 |
| Cruz, IA | 1 |
| Dillard, MG | 1 |
| Hosten, AO | 1 |
| White, MG | 2 |
| Lupu, AN | 1 |
| Pinggera, WF | 1 |
| Robinette, J | 1 |
| Halgrimson, CG | 1 |
| Butkus, DE | 1 |
| Gossain, VV | 1 |
| Ferrara, EV | 1 |
| Srivastava, L | 1 |
| Privitera, PJ | 1 |
| Hanenson, I | 1 |
| Morgan, TO | 1 |
| Toussaint, C | 1 |
| Verniory, A | 1 |
| Naets, JP | 1 |
| Corvilain, J | 1 |
| Lambert, PP | 1 |
| Marosi, J | 1 |
| Takó, J | 2 |
| Dévényi, I | 2 |
| Kaplan, NM | 1 |
| Kotchen, TA | 1 |
| Yoshinaga, H | 1 |
| Aida, M | 1 |
| Miura, Y | 1 |
| Blunck, W | 1 |
| Bierich, JR | 1 |
| Copeland, DL | 1 |
| Baumber, JS | 1 |
| Geddes, RA | 1 |
| Pawsey, CG | 1 |
| O'Halloran, MW | 1 |
| Vagnucci, AH | 3 |
| Rogers, PW | 1 |
| Pfaff, WW | 1 |
| Gentle, JL | 1 |
| Edwards, KD | 1 |
| Stewart, JH | 1 |
| Cushman, P | 1 |
| Lambertz, J | 1 |
| Caldera, R | 1 |
| Rossier, A | 1 |
| Hills, AG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Multicenter, Double-blind, Placebo-controlled, Randomized Withdrawal, Parallel Group Study of Patiromer for the Management of Hyperkalemia in Subjects Receiving Renin Angiotensin Aldosterone System Inhibitor (RAASi) Medications for the Treatment of Hear[NCT03888066] | Phase 3 | 1,195 participants (Actual) | Interventional | 2019-04-24 | Completed | ||
| Improving Outcomes in Diabetic Nephropathy[NCT00381134] | Phase 2 | 92 participants (Anticipated) | Interventional | 2003-07-31 | Completed | ||
| Glycyrrhetinic Acid-Effect on Serum Potassium and Insulin Resistance in Dialysis Patients[NCT00384384] | Phase 2 | 24 participants | Interventional | 2006-08-31 | Completed | ||
| [NCT01832558] | 24 participants (Anticipated) | Interventional | 2012-11-30 | Recruiting | |||
| Comparison of Citrate Dialysate in Predilution and Postdilution Online Hemodiafiltration : Effect on Clot Formation and Adequacy of Dialysis in Hemodialysis Patients[NCT05280106] | 9 participants (Actual) | Interventional | 2022-02-01 | Completed | |||
| The Effects of Clonidine on the Diuretic Response in Cirrhotic Patients With Ascites and Activation of Sympathetic Nervous System: a Randomized Double-Blind Placebo Controlled Study.[NCT00356226] | 64 participants | Interventional | 2000-10-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Adjusted mean changes in serum K+ from Baseline. (NCT03888066)
Timeframe: Mean duration of exposure: 227.9 days for Patiromer and 234.5 days for Placebo
| Intervention | Milliequivalents Per Liter (mEq/l) (Least Squares Mean) |
|---|---|
| Patiromer | 0.029 |
| Placebo | 0.127 |
"Participant's follow-up is from the date of the first dose of randomized study medication up to the participant's end of study date or 24 Jun 2021, whichever comes first.~Annualized event rate per 100 subject-years= The total number of events for all subjects in the treatment group divided by the total subject-years of follow-up in that treatment group multiplied by 100." (NCT03888066)
Timeframe: Mean duration of exposure: 227.9 days for Patiromer and 234.5 days for Placebo
| Intervention | Ann. event rate per 100 subject-years (Number) |
|---|---|
| Patiromer | 82.38 |
| Placebo | 114.65 |
"Cumulative incidence of the reduction of the MRA dose below target dose calculated as CIF Estimates (95% CI) over time.~Note: The reduction below the MRA target dose must last for at least 14 days (orless if at the end of study) to confirm this endpoint.~CIF = cumulative incidence function; mEq/l = Milliequivalents Per Liter" (NCT03888066)
Timeframe: From Day 1/Baseline to week 102
| Intervention | Probability (Number) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Week 1 | Week 2 | Week 6 | Week 18 | Week 30 | Week 42 | Week 54 | Week 66 | Week 78 | Week 90 | Week 102 | |
| Patiromer | 0.02 | 0.03 | 0.06 | 0.10 | 0.14 | 0.16 | 0.19 | 0.22 | 0.27 | 0.27 | 0.27 |
| Placebo | 0.04 | 0.08 | 0.12 | 0.15 | 0.19 | 0.23 | 0.26 | 0.27 | 0.29 | 0.29 | NA |
"Cumulative incidence of the first event of hyperkalemia with a serum K+ value >5.5 mEq/l taking death as competing and calculated as CIF Estimates (95% CI) over time.~Aalen-Johansen estimators of the cumulative incidence function with death as a competing event.~CIF = cumulative incidence function; mEq/l = Milliequivalents Per Liter" (NCT03888066)
Timeframe: From Day 1/Baseline to week 90
| Intervention | Probability (Number) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Week 1 | Week 2 | Week 6 | Week 18 | Week 30 | Week 42 | Week 54 | Week 66 | Week 78 | Week 90 | |
| Patiromer | 0.02 | 0.04 | 0.05 | 0.08 | 0.13 | 0.17 | 0.21 | 0.25 | 0.30 | 0.34 |
| Placebo | 0.04 | 0.08 | 0.10 | 0.14 | 0.20 | 0.24 | 0.29 | 0.34 | 0.34 | 0.34 |
"Analyzed using Win Ratio approach with the following hierarchical components:~Time to CV death~Total number of CV hospitalizations~Total number of hyperkalemia toxicity events with serum K+ >6.5 mEq/l~Total number of hyperkalemia events with serum K+ >6.0-6.5 mEq/l~Total number of hyperkalemia events with serum K+ >5.0 mEq/l~MHTE=More hyperkalemia toxicity events; MHE=More hyperkalemia events; CV=Cardiovascular" (NCT03888066)
Timeframe: Mean duration of exposure: 227.9 days for Patiromer and 234.5 days for Placebo
| Intervention | Events (Number) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CV death in Placebo Group First | CV death in Patiromer Group First | More CV hospitalizations in Placebo Group | More CV hospitalizations in Patiromer Group | MHTE with serum K+>6.5 in Placebo Group | MHTE with serum K+>6.5 in Patiromer Group | MHE with serum K+>6.0-6.5 in Placebo Group | MHE with serum K+>6.0-6.5 in Patiromer Group | MHE with serum K+>5.0-6.0 in Placebo Group | MHE with serum K+>5.0-6.0 in Patiromer Group | None of the above | Total number of pairs | |
| All Participants | 3491 | 4609 | 4539 | 4178 | 419 | 401 | 4283 | 1446 | 55633 | 34156 | 79566 | 192721 |
"RAASi use score (0 to 8 points) analyzed using the Win Ratio approach for each pair of participants with the following additive components:~All-cause death~Occurrence of a CV hospitalization~HF medication use and dose for i) an ACEi/ARB/ARNi, ii) a MRA, and iii) a beta-blocker~Each participant in each comparison can have 0-8 points and all participants are compared using this score at the respective appropriate follow-up time point.~RAASi=renin-angiotensin-aldosterone system inhibitor; ACEi=angiotensin converting enzyme inhibitor; ARB=angiotensin receptor blocker; ARNi=angiotensin receptor/neprilysin inhibitor; MRA=mineralocorticoid receptor antagonist." (NCT03888066)
Timeframe: Mean duration of exposure: 227.9 days for Patiromer and 234.5 days for Placebo
| Intervention | Events (Number) | |||
|---|---|---|---|---|
| Number of wins in Patiromer Group | Number of wins in Placebo Group | Number of ties | Total number of pairs | |
| All Participants | 62073 | 49733 | 80915 | 192721 |
74 reviews available for aldosterone and Hyperpotassemia
| Article | Year |
|---|---|
[Persistent and serious hyperkalemia after surgery of primary aldosteronism: A case report].
Topics: Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hyperkalemia; Potassium | 2022 |
A case of severe systemic type 1 pseudohypoaldosteronism with 10 years of evolution.
Topics: Aldosterone; Genetic Association Studies; Humans; Hyperkalemia; Hyponatremia; Pseudohypoaldosteronis | 2022 |
Aldosterone, Mineralocorticoid Receptor Activation, and CKD: A Review of Evolving Treatment Paradigms.
Topics: Aldosterone; Diabetes Mellitus, Type 2; Fibrosis; Humans; Hyperkalemia; Inflammation; Mineralocortic | 2022 |
Safety and efficacy of new potassium binders on hyperkalemia management in patients with heart failure: a systematic review and meta-analysis of randomized controlled trials.
Topics: Aldosterone; Angiotensins; Heart Failure; Humans; Hyperkalemia; Hypokalemia; Mineralocorticoid Recep | 2023 |
Recent progress in the diagnosis and treatment of primary aldosteronism.
Topics: Aldosterone; Glucose; Humans; Hyperaldosteronism; Hyperkalemia; Hypertension; Mineralocorticoid Rece | 2023 |
Mitigating risk of aldosterone in diabetic kidney disease.
Topics: Aldosterone; Cytochrome P-450 CYP11B2; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Hy | 2020 |
Hyperkalemia in type 4 renal tubular acidosis associated with systemic lupus erythematosus.
Topics: Acidosis; Adult; Aldosterone; Anti-Inflammatory Agents; Bicarbonates; Buffers; Female; Fludrocortiso | 2020 |
When should we start and stop ACEi/ARB in paediatric chronic kidney disease?
Topics: Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihyperte | 2021 |
[Hyperkalemia as a limiting factor in the use of drugs that block the Renin Angiotensin Aldosterone System (RAAS)].
Topics: Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Diuretics; | 2018 |
Hyperkalemic Forms of Renal Tubular Acidosis: Clinical and Pathophysiological Aspects.
Topics: Acidosis, Renal Tubular; Aldosterone; Animals; Epithelial Sodium Channels; Humans; Hydrogen-Ion Conc | 2018 |
Mineralocorticoid Antagonism and Diabetic Kidney Disease.
Topics: Adult; Albuminuria; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; | 2019 |
Failure to thrive, hyponatremia, and hyperkalemia in a neonate.
Topics: Aldosterone; Diagnosis, Differential; Failure to Thrive; Humans; Hyperkalemia; Hyponatremia; Infant, | 2013 |
Comparison of agents that affect aldosterone action.
Topics: Aldosterone; Animals; Epithelial Sodium Channel Blockers; Humans; Hydrocortisone; Hyperaldosteronism | 2014 |
Mineralocorticoid receptor activation and mineralocorticoid receptor antagonist treatment in cardiac and renal diseases.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Aldosterone; Animals; Blood Pressure; Clinical Trials as Topi | 2015 |
Effect of mineralocorticoids on acid-base balance.
Topics: Acid-Base Equilibrium; Acidosis, Renal Tubular; Aldosterone; Angiotensin II; Bicarbonates; Epithelia | 2014 |
Aldosterone blockade in CKD: emphasis on pharmacology.
Topics: Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biological | 2015 |
Resistant Hypertension and the Pivotal Role for Mineralocorticoid Receptor Antagonists: A Clinical Update 2016.
Topics: Age Factors; Aldosterone; Blood Pressure Monitoring, Ambulatory; Comorbidity; Diabetes Mellitus; Hum | 2016 |
Potassium: friend or foe?
Topics: Aldosterone; Cation Exchange Resins; Cell Membrane; Child; Heart Failure; Homeostasis; Humans; Hyper | 2017 |
Mechanisms in hyperkalemic renal tubular acidosis.
Topics: Acidosis; Acidosis, Renal Tubular; Aldosterone; Ammonia; Animals; Epithelial Sodium Channels; Humans | 2009 |
Transient type 1 pseudo-hypoaldosteronism: report on an eight-patient series and literature review.
Topics: Acid-Base Imbalance; Aldosterone; Bicarbonates; Child; Child, Preschool; Creatinine; Drug Resistance | 2009 |
Aldosterone in uremia - beyond blood pressure.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Aldosterone; Endothelial Cells; Endothelium, Vascular; | 2010 |
Understanding the risk of hyperkalaemia in heart failure: role of aldosterone antagonism.
Topics: Aldosterone; Diuretics; Evidence-Based Medicine; Heart Failure; Humans; Hyperkalemia; Mineralocortic | 2010 |
Dual renin-angiotensin-aldosterone system blockade for diabetic kidney disease.
Topics: Albuminuria; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Benzimidazoles; Be | 2010 |
Aldosterone blockade in chronic kidney disease: can it improve outcome?
Topics: Aldosterone; Blood Pressure; Cardiovascular Diseases; Chronic Disease; Clinical Trials as Topic; Hum | 2010 |
Aldosterone antagonists in heart failure.
Topics: Aldosterone; Animals; Eplerenone; Heart Failure; Humans; Hyperkalemia; Mineralocorticoid Receptor An | 2011 |
[Pseudohypoaldosteronism type I].
Topics: Aldosterone; Child; Dialysis; Epithelial Sodium Channels; Humans; Hyperkalemia; Hyponatremia; Ion Ex | 2011 |
Aldosterone blockade and the mineralocorticoid receptor in the management of chronic kidney disease: current concepts and emerging treatment paradigms.
Topics: Aldosterone; Animals; Chelating Agents; Combined Modality Therapy; Disease Progression; Humans; Hype | 2012 |
Mineralocorticoid receptor activation in myocardial infarction and failure: recent advances.
Topics: Aldosterone; Genetic Techniques; Heart Failure; Humans; Hyperkalemia; Mineralocorticoid Receptor Ant | 2012 |
Effects of angiotensin II on kinase-mediated sodium and potassium transport in the distal nephron.
Topics: Aldosterone; Angiotensin II; Animals; Epithelial Sodium Channels; Humans; Hyperkalemia; Hypertension | 2013 |
[Primary hyperaldosteronism].
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocortical Hyperfunction; Aldosterone; Antihypertensive Agent | 2003 |
METABOLIC MYOPATHIES. THE GLYCOGENOSES AFFECTING MUSCLE, AND HYPO- AND HYPERKALEMIC PERIODIC PARALYSIS.
Topics: Aldosterone; Carbohydrate Metabolism; Glucose-6-Phosphatase; Glucosidases; Glycogen Storage Disease; | 1963 |
Aldosterone synthase deficiency and related disorders.
Topics: Adrenal Hyperplasia, Congenital; Aldosterone; Cortisone; Cytochrome P-450 CYP11B2; Exons; Humans; Hy | 2004 |
Mineralocorticoid receptor antagonists and hypertension: is there a rationale?
Topics: Albuminuria; Aldosterone; Animals; Drug Therapy, Combination; Eplerenone; Humans; Hyperkalemia; Hype | 2004 |
Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system.
Topics: Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Humans; Hyp | 2004 |
Aldosterone blockade in cardiovascular disease.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiology; Cardiovascular Diseases; | 2004 |
[Hypokalemia and Hyperkalemia].
Topics: Adrenergic beta-Agonists; Aldosterone; Diagnosis, Differential; Gluconates; Humans; Hyperkalemia; Hy | 2006 |
[Acquired selective hypoaldosteronism].
Topics: Acidosis; Adrenal Cortex; Adrenal Gland Neoplasms; Aldosterone; Diabetes Complications; Humans; Hype | 2006 |
Type 2 pseudohypoaldosteronism: new insights into renal potassium, sodium, and chloride handling.
Topics: Adult; Aldosterone; Chlorides; Electrolytes; Humans; Hyperkalemia; Intracellular Signaling Peptides | 2006 |
Aldosterone blockade: an emerging strategy for abrogating progressive renal disease.
Topics: Aldosterone; Algorithms; Disease Progression; Disease Susceptibility; Drug Labeling; Eplerenone; Fib | 2006 |
Exogenous mineralocorticoid-like disorders.
Topics: Adult; Aldosterone; Animals; Carbenoxolone; Emollients; Female; Fludrocortisone; Fluprednisolone; Gl | 1981 |
Internal potassium balance and the control of the plasma potassium concentration.
Topics: Acid-Base Imbalance; Aldosterone; Cardiac Glycosides; Catecholamines; Extracellular Space; Familial | 1981 |
Clinical disorders of aldosterone metabolism.
Topics: Acidosis; Adrenal Hyperplasia, Congenital; Aldosterone; Bartter Syndrome; Cushing Syndrome; Diagnosi | 1984 |
[Hyporeninemic hypoaldosteronism and the differential diagnosis of hyperkalemia].
Topics: Acid-Base Equilibrium; Acidosis, Renal Tubular; Adrenal Cortex; Adult; Aldosterone; Diagnosis, Diffe | 1982 |
[Hyporeninemic hypoaldosteronism associated with diabetes mellitus].
Topics: Aldosterone; Diabetes Mellitus; Humans; Hyperkalemia; Juxtaglomerular Apparatus; Renin; Renin-Angiot | 1982 |
Distal renal tubular acidosis: pathogenesis and classification.
Topics: Acidosis, Renal Tubular; Aldosterone; Bicarbonates; Carbon Dioxide; Humans; Hydrogen-Ion Concentrati | 1982 |
Pathophysiology of the syndrome of hyporeninemic hypoaldosteronism.
Topics: Acidosis; Aged; Aldosterone; Ammonia; Angiotensin II; Bicarbonates; Cations, Monovalent; Extracellul | 1980 |
[Hyporeninemic hypoaldosteronism].
Topics: Acidosis; Adrenal Cortex Hormones; Adult; Aged; Aldosterone; Chlorides; Diagnosis, Differential; Hum | 1981 |
Potassium handling by the kidney. Hyperkalaemia.
Topics: Acid-Base Equilibrium; Aldosterone; Animals; Humans; Hyperkalemia; Intracellular Fluid; Kidney Disea | 1981 |
Clinical disorders of hyperkalemia.
Topics: Acid-Base Imbalance; Addison Disease; Adrenal Hyperplasia, Congenital; Adult; Aged; Aldosterone; Cat | 1982 |
Heparin-induced aldosterone suppression and hyperkalemia.
Topics: Adrenal Glands; Aldosterone; Animals; Heparin; Humans; Hyperkalemia; Potassium | 1995 |
Type II pseudohypoaldosteronism. Report of a case and review of the literature.
Topics: Aldosterone; Atrial Natriuretic Factor; Female; Humans; Hyperkalemia; Hypertension; Middle Aged; Pot | 1994 |
Tissue renin angiotensin systems: theoretical implications for the development of hyperkalemia using angiotensin-converting enzyme inhibitors.
Topics: Adrenal Glands; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Humans; Hyperkalemia | 1994 |
[Iatrogenic hyperkalemia].
Topics: Aldosterone; Drug-Related Side Effects and Adverse Reactions; Humans; Hyperkalemia; Iatrogenic Disea | 1996 |
Hyperkalemic hyperchloremic metabolic acidosis: pathophysiologic insights.
Topics: Acidosis; Acquired Immunodeficiency Syndrome; Adult; Aldosterone; Animals; Chlorides; Disease Models | 1997 |
Molecular and pathophysiologic mechanisms of hyperkalemic metabolic acidosis.
Topics: Acidosis; Aldosterone; Ammonia; Chlorine; Genes, Dominant; Genes, Recessive; Humans; Hyperkalemia; K | 2000 |
Renal tubular acidosis syndromes.
Topics: Acidosis, Renal Tubular; Aldosterone; Female; Humans; Hyperkalemia; Hypokalemia; Male | 2000 |
Hyperkalemia: An adaptive response in chronic renal insufficiency.
Topics: Adaptation, Physiological; Aldosterone; Animals; Homeostasis; Humans; Hyperkalemia; Kidney; Kidney F | 2002 |
Hyporeninemic hypoaldosteronism.
Topics: Acidosis; Aldosterone; Ammonia; Carbon Dioxide; Diagnosis, Differential; Female; Fludrocortisone; Hu | 1979 |
[Pure hypoaldosteronism in the adult].
Topics: Adrenal Glands; Adrenal Insufficiency; Adult; Aged; Aldosterone; Angiotensin II; Child; Glucocortico | 1975 |
The defense against hyperkalemia: the roles of insulin and aldosterone.
Topics: Aldosterone; Animals; Diabetes Mellitus; Dogs; Homeostasis; Humans; Hyperkalemia; Insulin; Insulin S | 1978 |
[Isolated hypoaldosteronism in adults. Role of diabetes].
Topics: Aldosterone; Diabetes Complications; Fludrocortisone; Humans; Hyperkalemia; Kidney Diseases; Renin; | 1979 |
The syndrome of hyporeninemic hypoaldosteronism.
Topics: Acidosis; Aldosterone; Alkalies; Diagnosis, Differential; Humans; Hyperkalemia; Renin; Syndrome | 1979 |
Hyperkalemia in the elderly.
Topics: Aged; Aging; Aldosterone; Drug-Related Side Effects and Adverse Reactions; Humans; Hyperkalemia; Hyp | 1990 |
Primary acquired hypoaldosteronism.
Topics: Absorption; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Biological Transport, Active; | 1985 |
Syndrome of hypertension and hyperkalemia with normal glomerular filtration rate.
Topics: Adolescent; Adult; Aldosterone; Bicarbonates; Blood Pressure; Child; Diet, Sodium-Restricted; Diuret | 1986 |
[Type IV renal tubular acidosis].
Topics: Acidosis, Renal Tubular; Aldosterone; Bicarbonates; Diabetes Complications; Humans; Hyperkalemia; Ki | 1985 |
[Metabolic disturbances in renal tubular acidosis: water-electrolyte balance].
Topics: Absorption; Acidosis, Renal Tubular; Aldosterone; Bicarbonates; Body Water; Chlorine; Humans; Hydrog | 1985 |
Pseudohypoaldosteronism: a review and report of two new cases.
Topics: Adrenocorticotropic Hormone; Aldosterone; Child; Colon; Female; Humans; Hydrocortisone; Hyperkalemia | 1986 |
Hyperkalemia.
Topics: Acid-Base Equilibrium; Aldosterone; Arrhythmias, Cardiac; Heart Block; Humans; Hyperkalemia; Insulin | 1986 |
The clinical spectrum of renal tubular acidosis.
Topics: Acidosis, Renal Tubular; Adult; Aldosterone; Ammonium Chloride; Animals; Bicarbonates; Bone Diseases | 1986 |
[Type IV renal tubular acidosis: pathogenetic role of aldosterone deficiency and hyperkalemia].
Topics: Acidosis, Renal Tubular; Aldosterone; Diet; Fludrocortisone; Humans; Hyperkalemia; Potassium | 1985 |
[Distal renal tubular acidosis. B. Voltage dependent type].
Topics: Acidosis, Renal Tubular; Aldosterone; Humans; Hyperkalemia; Kidney Tubules, Distal | 1985 |
[Primary hypo- and hyperreninism].
Topics: Addison Disease; Adolescent; Adult; Aldosterone; Angiotensin II; Blood Volume; Diagnosis, Differenti | 1974 |
The role of aldosterone in renal physiology.
Topics: Acid-Base Equilibrium; Aldosterone; Animals; Dogs; Humans; Hyperkalemia; Kidney; Kidney Tubules; Pot | 1973 |
17 trials available for aldosterone and Hyperpotassemia
| Article | Year |
|---|---|
A randomized study to compare oral potassium binders in the treatment of acute hyperkalemia.
Topics: Aldosterone; Humans; Hyperkalemia; Potassium; Renal Dialysis; Renin-Angiotensin System | 2023 |
Safety, Tolerability, and Pharmacokinetics of the Mineralocorticoid Receptor Modulator AZD9977 in Healthy Men: A Phase I Multiple Ascending Dose Study.
Topics: Administration, Oral; Adolescent; Adult; Aldosterone; Area Under Curve; Benzoates; Dose-Response Rel | 2020 |
Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial.
Topics: Adult; Aged; Aldosterone; Cardiovascular Diseases; Diastole; Dose-Response Relationship, Drug; Doubl | 2019 |
Potassium handling with dual renin-angiotensin system inhibition in diabetic nephropathy.
Topics: Adult; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitor | 2014 |
Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors.
Topics: Aged; Albuminuria; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzy | 2016 |
Glycyrrhetinic acid food supplementation lowers serum potassium concentration in chronic hemodialysis patients.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Aged; Aged, 80 and over; Aldosterone; Biomarkers; Blood | 2009 |
Potassium-lowering effect of mineralocorticoid therapy in patients undergoing hemodialysis.
Topics: Adult; Aged; Aldosterone; Blood Glucose; Epinephrine; Fludrocortisone; Humans; Hyperkalemia; Insulin | 2002 |
Is spironolactone safe for dialysis patients?
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Female; Humans; Hyperkalemia; Kidney Failure, Chronic; | 2003 |
Safety of low-dose spironolactone administration in chronic haemodialysis patients.
Topics: Adult; Aged; Aldosterone; Canrenone; Humans; Hyperkalemia; Kidney Failure, Chronic; Middle Aged; Min | 2003 |
Early onset of hyperkalemia in patients treated with low molecular weight heparin: a prospective study.
Topics: Aldosterone; Anticoagulants; Creatinine; Enoxaparin; Female; Humans; Hydrogen-Ion Concentration; Hyp | 2004 |
Heparin-induced hyperkalemia in chronic hemodialysis patients: comparison of low molecular weight and unfractionated heparin.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Anticoagulants; Bicarbonates; Creatinine; Cross-Over Studi | 1998 |
Renin-aldosterone system can respond to furosemide in patients with hyperkalemic hyporeninism.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Antihypertensive Agents; Atrial Natriuretic Factor; Cap | 1998 |
Nonselective Beta-adrenergic blockade augments fasting hyperkalemia in hemodialysis patients.
Topics: Adrenergic beta-Antagonists; Adult; Aldosterone; Blood Glucose; Blood Pressure; Fasting; Female; Hum | 2002 |
Acute hyperkalemia induced by hyperglycemia: hormonal mechanisms.
Topics: Acute Disease; Adrenal Cortex Function Tests; Adult; Aldosterone; Clinical Trials as Topic; Desoxyco | 1976 |
Renal acidification in patients with mineralocorticoid deficiency.
Topics: Acid-Base Equilibrium; Acidosis; Addison Disease; Adrenalectomy; Adult; Aged; Aldosterone; Bicarbona | 1976 |
Inducing hyperkalemia by converting enzyme inhibitors and heparin.
Topics: Acidosis; Acute Kidney Injury; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, | 1988 |
Effects of angiotensin on plasma electrolyte concentrations in rabbits and in man.
Topics: Adrenal Glands; Adrenalectomy; Adult; Aldosterone; Angiotensin II; Animals; Arteries; Blood Pressure | 1974 |
307 other studies available for aldosterone and Hyperpotassemia
| Article | Year |
|---|---|
Cost-Effectiveness of Treating Patients with Chronic Kidney Disease and Prior Hyperkalemia with Renin-Angiotensin-Aldosterone System Inhibitor and Patiromer: A Swiss Public Healthcare Perspective.
Topics: Aldosterone; Antihypertensive Agents; Cost-Benefit Analysis; Delivery of Health Care; Humans; Hyperk | 2022 |
Managing Hyperkalemia to Enable Guideline-Recommended Dosing of Renin-Angiotensin-Aldosterone System Inhibitors.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Humans; Hyperkalemia; Mineralocorticoid Recep | 2022 |
A 77-Year-Old Man with Heparin-Induced Aldosterone Suppression Causing Hyperkalemia.
Topics: Aged; Aldosterone; Anticoagulants; COVID-19; Heparin; Humans; Hyperkalemia; Male; Potassium | 2022 |
Balancing Hyperkalemia Risks with Clinical Benefits of Renin-Angiotensin-Aldosterone Inhibitors/Mineralocorticoid Receptor Antagonists Blockade: It's Apples and Oranges.
Topics: Aldosterone; Angiotensin Receptor Antagonists; Angiotensins; Antihypertensive Agents; Humans; Hyperk | 2022 |
Prognostic value of contralateral suppression on kidney function after surgery in patients with primary aldosteronism.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hyperkalemia; Kidney; Progno | 2023 |
Salt-Losing Syndrome in a Girl with Type I and II Pseudohypoaldosteronism.
Topics: Acidosis; Aldosterone; Female; Humans; Hyperkalemia; Hypertension; Hyponatremia; Infant; Pseudohypoa | 2022 |
Clinical manifestations and associated factors in acquired hypoaldosteronism in endocrinological practice.
Topics: Acidosis; Addison Disease; Adult; Aldosterone; Female; Humans; Hyperkalemia; Hypoaldosteronism; Hypo | 2022 |
Outcomes in patients with cardiometabolic disease who develop hyperkalemia while treated with a renin-angiotensin-aldosterone system inhibitor.
Topics: Adult; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Coronary Arte | 2023 |
Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Enzyme Inhibitors; H | 2023 |
ER ribosomal-binding protein 1 regulates blood pressure and potassium homeostasis by modulating intracellular renin trafficking.
Topics: Aldosterone; Aluminum Oxide; Animals; Blood Pressure; Carrier Proteins; Genome-Wide Association Stud | 2023 |
Usefulness of Alternative Therapy with Hydrocortisone in the Postoperative Management of Severe Primary Aldosteronism.
Topics: Adrenalectomy; Aldosterone; Humans; Hydrocortisone; Hyperaldosteronism; Hyperkalemia; Hypertension; | 2023 |
A cost-effectiveness analysis of patiromer in the UK: evaluation of hyperkalaemia treatment and lifelong RAASi maintenance in chronic kidney disease patients with and without heart failure.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cost-Effectiveness A | 2023 |
Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors Secondary to Hyperkalemia Translates into Higher Cardiorenal Outcomes.
Topics: Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiov | 2023 |
Calcineurin regulates aldosterone production via dephosphorylation of NFATC4.
Topics: Aldosterone; Animals; Calcineurin; Cytochrome P-450 CYP11B2; Humans; Hyperkalemia; Mice; NFATC Trans | 2023 |
Prolonged postoperative hypoaldosteronism related to hyperkalemia in patients with aldosterone-producing adenoma.
Topics: Adenoma; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Hyperkalemi | 2023 |
Hyporeninemic hypoaldosteronism in RMND1-related mitochondrial disease.
Topics: Aldosterone; Cell Cycle Proteins; Child; Electrolytes; Humans; Hyperkalemia; Hypoaldosteronism; Mito | 2024 |
Impact of Sodium Zirconium Cyclosilicate Plus Renin-Angiotensin-Aldosterone System Inhibitor Therapy on Short-Term Medical Costs in Hyperkalemia: OPTIMIZE II Real-World Study.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Humans; Hyperkalemia | 2023 |
Maintaining Renin-Angiotensin-Aldosterone System Inhibitor Treatment with Patiromer in Hyperkalaemic Chronic Kidney Disease Patients: Comparison of a Propensity-Matched Real-World Population with AMETHYST-DN.
Topics: Adult; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetes Mell | 2023 |
Risk of hyperkalemia from renin-angiotensin-aldosterone system inhibitors and factors associated with treatment discontinuities in a real-world population.
Topics: Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetes Melli | 2021 |
[Stress the standardized diagnosis and management of primary aldosteronism].
Topics: Adenoma; Aldosterone; Humans; Hyperaldosteronism; Hyperkalemia; Hypertension; Renin | 2020 |
Failure to Thrive, Hyponatremia, Hyperkalemia - Differential Diagnostic Reflections of a Rare Genetic Disease.
Topics: Adult; Aldosterone; Child, Preschool; Diagnosis, Differential; Failure to Thrive; Humans; Hyperkalem | 2020 |
Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry.
Topics: Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensin | 2020 |
Letter regarding the article 'Effects of hyperkalaemia and non-adherence to renin-angiotensin-aldosterone system inhibitor therapy in patients with heart failure in Italy: a propensity-matched study'.
Topics: Aldosterone; Heart Failure; Humans; Hyperkalemia; Italy; Renin-Angiotensin System | 2021 |
Aldosterone synthase (CYP11B2) deficiency among Palestinian infants: Three novel variants and genetic heterogeneity.
Topics: Aldosterone; Arabs; Cytochrome P-450 CYP11B2; Female; Genetic Heterogeneity; Humans; Hyperkalemia; H | 2021 |
Effects of hyperkalaemia and non-adherence to renin-angiotensin-aldosterone system inhibitor therapy in patients with heart failure in Italy: a propensity-matched study.
Topics: Aged; Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cohor | 2020 |
Reply to the letter regarding the article 'Effects of hyperkalaemia and non-adherence to renin-angiotensin-aldosterone system inhibitor therapy in patients with heart failure in Italy: a propensity-matched study'.
Topics: Aldosterone; Heart Failure; Humans; Hyperkalemia; Italy; Renin-Angiotensin System | 2021 |
Recurrent Hyperkalemia in Renin-Angiotensin-Aldosterone System Inhibitor (RAASi) Treatment: Stuck between a Rock and a Hard Place.
Topics: Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Humans; Hyp | 2021 |
High aldosterone and cortisol levels in salt wasting congenital adrenal hyperplasia: a clinical conundrum.
Topics: Acidosis; Adrenal Hyperplasia, Congenital; Aldosterone; Child; Dehydration; Diagnosis, Differential; | 2017 |
Contralateral suppression of aldosterone at adrenal venous sampling predicts hyperkalemia following adrenalectomy for primary aldosteronism.
Topics: Adrenalectomy; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hyperkalemia; Incidence; Male | 2018 |
Is hyperkalaemia in heart failure a risk factor or a risk marker? Implications for renin-angiotensin-aldosterone system inhibitor use.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Heart Failure; Humans; Hyperkalemia; Potassiu | 2018 |
Maximizing benefits and mitigating risks with mineralocorticoid receptor antagonist therapy.
Topics: Aldosterone; Heart Failure; Humans; Hyperkalemia; Incidence; Mineralocorticoid Receptor Antagonists; | 2018 |
A potential serious complication in infants with congenital obstructive uropathy: Secondary pseudohypoaldosteronism.
Topics: Aldosterone; Diagnosis, Differential; Female; Humans; Hyperkalemia; Hyponatremia; Infant; Male; Natr | 2019 |
An infant with hyponatremia, hyperkalemia, and metabolic acidosis associated with urinary tract infection: Answers.
Topics: Acidosis; Aldosterone; Anti-Bacterial Agents; Female; Humans; Hyperkalemia; Hyponatremia; Infant; Ps | 2019 |
Familial hyperkalemia and hypertension and a hypothesis to explain proximal renal tubular acidosis.
Topics: Acidosis, Renal Tubular; Aldosterone; Chlorides; Humans; Hyperkalemia; Hypertension; Protein Serine- | 2019 |
Incidence and factors of post-adrenalectomy hyperkalemia in patients with aldosterone producing adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Female; H | 2013 |
K+-induced natriuresis is preserved during Na+ depletion and accompanied by inhibition of the Na+-Cl- cotransporter.
Topics: Aldosterone; Angiotensin II; Animals; Hyperkalemia; Male; Natriuresis; Potassium, Dietary; Rats; Rat | 2013 |
Functional coupling of renal K+ and Na+ handling causes high blood pressure in Na+ replete mice.
Topics: Aldosterone; Animals; Blood Pressure; Hyperkalemia; Hypertension, Renal; Kidney; Male; Mice; Mice, I | 2014 |
A clinical prediction score for diagnosing unilateral primary aldosteronism may not be generalizable.
Topics: Adrenal Glands; Adult; Aldosterone; Cosyntropin; Female; Glomerular Filtration Rate; Humans; Hydroco | 2014 |
Clinical risk factors of postoperative hyperkalemia after adrenalectomy in patients with aldosterone-producing adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Female; H | 2015 |
A neonate with poor weight gain and hyperkalemia: Answers.
Topics: Aldosterone; Humans; Hyperkalemia; Hyponatremia; Infant, Newborn; Pseudohypoaldosteronism; Weight Ga | 2017 |
Renal tubular acidosis type 4 in pregnancy.
Topics: Acid-Base Equilibrium; Acidosis, Renal Tubular; Adult; Aldosterone; Ammonia; Female; Humans; Hydroge | 2016 |
(Pro)Renin receptor regulates potassium homeostasis through a local mechanism.
Topics: Adrenalectomy; Aldosterone; Animals; Cytochrome P-450 CYP11B2; Disease Models, Animal; Epithelial So | 2017 |
Gastrointestinal potassium binding-more than just lowering serum [K(+)]: patiromer, potassium balance, and the renin angiotensin aldosterone axis.
Topics: Aldosterone; Angiotensins; Humans; Hyperkalemia; Polymers; Potassium; Renin; Renin-Angiotensin Syste | 2016 |
Hypothesis: a simple algorithm to distinguish between hypoaldosteronism and renal aldosterone resistance in patients with persistent hyperkalemia.
Topics: Aldosterone; Algorithms; Glomerular Filtration Rate; Humans; Hyperkalemia; Hypoaldosteronism; Kidney | 2008 |
Persistent hyperkalaemia.
Topics: Aged, 80 and over; Aldosterone; Female; Humans; Hyperkalemia; Hypoaldosteronism; Potassium | 2009 |
Expression and phosphorylation of the Na+-Cl- cotransporter NCC in vivo is regulated by dietary salt, potassium, and SGK1.
Topics: Aldosterone; Animals; Diuresis; Hyperkalemia; Immediate-Early Proteins; Kidney; Mice; Mice, Knockout | 2009 |
Case report: severe neonatal hyperkalemia due to pseudohypoaldosteronism type 1.
Topics: Aldosterone; Citrates; Dietary Supplements; Electrocardiography; Epithelial Sodium Channels; Female; | 2009 |
Association of aldosterone concentration and mineralocorticoid receptor genotype with potassium response to spironolactone in patients with heart failure.
Topics: Adult; Aged; Aldosterone; Angiotensinogen; Black or African American; Cohort Studies; Diuretics; Fem | 2010 |
Hyperpotassemia and bradycardia in a bedridden elderly woman with selective hypoaldosteronism associated with low renin activity.
Topics: Aged; Aged, 80 and over; Aging; Aldosterone; Anti-Inflammatory Agents, Non-Steroidal; Bradycardia; E | 2010 |
Hook effect: a pitfall leading to misdiagnosis of hypoaldosteronism in an infant with pseudohypoaldosteronism.
Topics: Aldosterone; Cytochrome P-450 CYP11B2; Diagnosis, Differential; Humans; Hyperkalemia; Hypoaldosteron | 2010 |
A physiologic-based approach to the evaluation of a patient with hyperkalemia.
Topics: Adult; Aldosterone; Chronic Disease; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Glomerular Fi | 2010 |
An unusual case of hyperkalaemia in infancy: question.
Topics: Acid-Base Equilibrium; Acidosis; Aldosterone; Biomarkers; Diet, Sodium-Restricted; Glomerular Filtra | 2011 |
Transient pseudohypoaldosteronism masquerading as congenital adrenal hyperplasia.
Topics: Adrenal Hyperplasia, Congenital; Aldosterone; Chimerism; Chromosome Aberrations; Diagnosis, Differen | 2011 |
[The EMPHASIS-HF study].
Topics: Aldosterone; Biomarkers; Canrenone; Cause of Death; Double-Blind Method; Early Termination of Clinic | 2011 |
What is the role of aldosterone excess in resistant hypertension and how should it be investigated and treated?
Topics: Aldosterone; Eplerenone; Female; Humans; Hyperaldosteronism; Hyperkalemia; Hypertension; Male; Miner | 2011 |
[Adrenal hyperplasia and hyperkalemia].
Topics: Adrenal Glands; Aldosterone; Diagnosis, Differential; Humans; Hyperkalemia; Hyperplasia; Hypoaldoste | 2002 |
Reversible secondary pseudohypoaldosteronism due to pyelonephritis.
Topics: Acute Disease; Aldosterone; Failure to Thrive; Humans; Hyperkalemia; Hyponatremia; Infant; Male; Phi | 2002 |
Hypoaldosteronism; a clinical study of a patient with an isolated adrenal mineralocorticoid deficiency, resulting in hyperkalemia and Stokes-Adams attacks.
Topics: Adams-Stokes Syndrome; Adrenal Hyperplasia, Congenital; Aldosterone; Heart Block; Humans; Hyperkalem | 1957 |
Hypoaldosteronism as a cause of hyperkalemia and syncopal attacks in a patient with complete heart block.
Topics: Aldosterone; Atrioventricular Block; Cardiovascular Diseases; Heart Block; Humans; Hyperkalemia; Hyp | 1961 |
Use of spironolactone in renal edema. Effectiveness and association with hyperkalemia.
Topics: Aldosterone; Diuretics; Edema; Humans; Hyperkalemia; Kidney; Kidney Diseases; Mineralocorticoid Rece | 1961 |
The effects of alteration of plasma sodium and potassium concentration on aldosterone secretion.
Topics: Aldosterone; Humans; Hyperkalemia; Hyponatremia; Potassium; Sodium | 1963 |
EFFECT OF AN ALDOSTERONE ANTAGONIST (SPIRONOLACTONE) ON PATIENTS WITH SEVERE CONGESTIVE HEART FAILURE.
Topics: Aldosterone; Antihypertensive Agents; Body Fluids; Diuresis; Diuretics; Female; Geriatrics; Heart Fa | 1963 |
[ON THE ELECTROLYTE AND ALDOSTERONE METABOLISM IN ADYNAMIA EPISODICA HEREDITARIA, THE HYPERKALEMIC FORM OF PERIODIC PARALYSIS].
Topics: Aldosterone; Electrolytes; Humans; Hydrocortisone; Hyperkalemia; Paralyses, Familial Periodic; Paral | 1964 |
[NEPHROLOGICAL PROBLEMS IN ADDISON'S DISEASE].
Topics: Addison Disease; Adrenal Insufficiency; Aldosterone; Humans; Hyperkalemia; Hypoadrenocorticism, Fami | 1964 |
SELECTIVE HYPOALDOSTERONISM AFTER PROLONGED HEPARIN ADMINISTRATION. A CASE REPORT, WITH POSTMORTEM FINDINGS.
Topics: Adrenal Cortex Hormones; Adrenal Insufficiency; Aldosterone; Blood; Heparin; Hypercholesterolemia; H | 1964 |
[INVESTIGATION OF THE BIOLOGICAL ACTIVITIES OF TRIAMCINOLONE DIACETATE IN PATIENTS WITH ADRENAL INSUFFICIENCY].
Topics: Adrenal Cortex Hormones; Adrenal Insufficiency; Adrenalectomy; Aldosterone; Blood; Blood Pressure; B | 1964 |
AN ALDOSTERONE BIOSYNTHETIC DEFECT IN A SALT-LOSING DISORDER.
Topics: Addison Disease; Adrenal Cortex Hormones; Adrenal Insufficiency; Adrenocortical Hyperfunction; Aldos | 1964 |
[A NEW HEREDITARY ENZYME DEFECT IN ALDOSTERONE SYNTHESIS (18-OXIDATION DEFECT)].
Topics: Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adrenogenital Syndrome; Aldosterone; B | 1964 |
[INFLUENCE OF SODIUM AND ALDOSTERONE ON THE MINERAL UNBALANCE FOLLOWING ABLATION OF THE CORPUSCLES OF STANNIUS IN THE EEL (ANGUILLA ANGUILLA L.)].
Topics: Adrenalectomy; Aldosterone; Anguilla; Animals; Eels; Hyperkalemia; Hyponatremia; Minerals; Pharmacol | 1964 |
A NEW HEREDITARY DEFECT IN THE BIOSYNTHESIS OF ALDOSTERONE: URINARY C21-CORTICOSTEROID PATTERN IN THREE RELATED PATIENTS WITH A SALT-LOSING SYNDROME, SUGGESTING AN 18-OXIDATION DEFECT.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adolescent; Adrenal Cortex Hormones; Adrenocorticotropic | 1964 |
Aldosterone resistance in kidney transplantation is in part induced by a down-regulation of mineralocorticoid receptor expression.
Topics: Acidosis; Adult; Aldosterone; Body Water; Calcineurin Inhibitors; Cyclosporine; Down-Regulation; Flu | 2004 |
[Hyperkalemia in the chronic renal failure: is it always the aldosterone the responsible?].
Topics: Aldosterone; Humans; Hyperkalemia; Kidney Failure, Chronic; Potassium | 1982 |
Treatment of heart failure with spironolactone--trial and tribulations.
Topics: Adrenergic beta-Antagonists; Aging; Aldosterone; Drug Therapy, Combination; Glomerular Filtration Ra | 2004 |
Hyperkalaemia with cyclooxygenase-2 inhibition and hypoaldosteronism.
Topics: Adult; Aldosterone; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Follow-Up Studies; Humans; Hyperk | 2005 |
[Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenalectomy; Adult; Aged; Aldosterone; Cytochrome P-450 CYP11B2 | 2006 |
Mineralocorticoid-receptor blockade, hypertension and heart failure.
Topics: Aldosterone; Clinical Trials as Topic; Eplerenone; Heart Failure; Hormone Antagonists; Humans; Hyper | 2005 |
WNK4 regulates activity of the epithelial Na+ channel in vitro and in vivo.
Topics: Aldosterone; Animals; Colon; Epithelial Sodium Channels; Hyperkalemia; Hypertension; Mice; Mice, Tra | 2007 |
[Change in potassium tolerance and urinary excretion of electrolytes among rats reared in a warm climate].
Topics: Adrenal Glands; Aldosterone; Animals; Drug Tolerance; Hyperkalemia; Male; Natriuresis; Organ Size; P | 1967 |
[Primary hypoaldosteronism and secondary pseudo-hypoaldosteronism].
Topics: Adult; Aldosterone; Angiotensin II; Bicarbonates; Fludrocortisone; Humans; Hyperkalemia; Hyponatremi | 1984 |
Adrenergic modulation of extrarenal potassium disposal.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aldosterone; Catecholamines; Epinephrine; Female; Homeosta | 1980 |
Influence of glucagon on plasma levels of potassium in man.
Topics: Adult; Aldosterone; Blood Glucose; Female; Glucagon; Humans; Hyperkalemia; Insulin; Male; Potassium; | 1980 |
Mineralocorticoid unresponsiveness with severe neonatal hyponatremia and hyperkalemia.
Topics: 17-Hydroxycorticosteroids; Adrenocorticotropic Hormone; Aldosterone; Female; Humans; Hyperkalemia; H | 1980 |
Heparin-induced hyperkalemia: report of a case.
Topics: Adrenocorticotropic Hormone; Aged; Aldosterone; Diabetes Complications; Diabetes Mellitus; Heparin; | 1980 |
Studies of the renal vasoactive systems in hyporeninemic hypoaldosteronism.
Topics: Adrenocorticotropic Hormone; Aged; Aldosterone; Female; Fludrocortisone; Furosemide; Humans; Hydroco | 1981 |
Insulin and beta receptor modulation of K homeostasis in nephrectomized dogs with hyperkalemia.
Topics: Aldosterone; Animals; Dogs; Female; Homeostasis; Hyperkalemia; Insulin; Male; Nephrectomy; Potassium | 1982 |
Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril.
Topics: Adolescent; Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; G | 1982 |
[Hyporeninemic hypoaldosteronism. A case report].
Topics: Adrenocorticotropic Hormone; Aged; Aldosterone; Female; Humans; Hyperkalemia; Hypothyroidism; Renin | 1983 |
[Hyporeninemic hypoaldosteronism with hyperpotassemia. Clinical and physiopathologic study of 18 cases].
Topics: Adrenocorticotropic Hormone; Aged; Aldosterone; Anti-Inflammatory Agents; Creatine; Female; Humans; | 1983 |
Amelioration of metabolic acidosis by dietary potassium restriction in hyperkalemic patients with chronic renal insufficiency.
Topics: Acidosis, Renal Tubular; Aged; Aldosterone; Ammonia; Humans; Hydrogen-Ion Concentration; Hyperkalemi | 1984 |
Relation between plasma aldosterone concentration and renal handling of sodium and potassium, in particular in patients with chronic renal failure.
Topics: Adolescent; Adult; Aldosterone; Female; Humans; Hyperkalemia; Hypokalemia; Kidney Failure, Chronic; | 1984 |
Hyperkalaemia in diabetes mellitus--potential hazards of coexisting hyporeninaemic hypoaldosteronism.
Topics: Adult; Aldosterone; Diabetes Mellitus, Type 1; Female; Humans; Hyperkalemia; Male; Middle Aged; Reni | 1984 |
Hyporeninemic hypoaldosteronism in two patients with systemic lupus erythematosus.
Topics: 18-Hydroxycorticosterone; Adolescent; Aldosterone; Aspirin; Female; Fludrocortisone; Humans; Hyperka | 1984 |
Hyporeninemic hypoaldosteronism in a patient with multiple myeloma.
Topics: Acidosis; Aldosterone; Humans; Hyperkalemia; Kidney Failure, Chronic; Kidney Neoplasms; Male; Middle | 1984 |
[Primary hypoaldosteronism, pseudo-hypoaldosteronism and distal tubular acidosis].
Topics: Acidosis, Renal Tubular; Adult; Aldosterone; Blood Pressure; Child; Diagnosis, Differential; Humans; | 1984 |
The syndrome of hyporeninemic hypoaldosteronism.
Topics: Aged; Aldosterone; Female; Humans; Hyperkalemia; Kidney Failure, Chronic; Male; Middle Aged; Renin; | 1984 |
Coincidence of pseudohypoaldosteronism with gluten-enteropathy.
Topics: Aldosterone; Celiac Disease; Chlorides; HLA Antigens; Humans; Hyperkalemia; Hyponatremia; Infant; Ki | 1984 |
Prediction of hyperkalemia associated with prolonged treatment with captopril by glucose-induced acute serum potassium changes.
Topics: Aldosterone; Blood Pressure; Captopril; Glucose; Glucose Tolerance Test; Humans; Hyperkalemia; Hyper | 1984 |
Heparin side effects.
Topics: Aged; Aldosterone; Female; Heparin; Humans; Hyperkalemia; Hypotension, Orthostatic | 1984 |
[Oxyphenbutazone-induced hyperkalemia in selective hypoaldosteronism in adults].
Topics: Age Factors; Aldosterone; Humans; Hyperkalemia; Male; Middle Aged; Oxyphenbutazone | 1983 |
Hyperkalemia from single small oral doses of potassium chloride.
Topics: Administration, Oral; Aldosterone; Diabetes Mellitus, Type 1; Homeostasis; Humans; Hyperkalemia; Mal | 1984 |
Effect of furosemide on urinary acidification in distal renal tubular acidosis.
Topics: Acidosis, Renal Tubular; Aldosterone; Ammonia; Bicarbonates; Furosemide; Humans; Hydrogen-Ion Concen | 1984 |
Hyporeninemic hypoaldosteronism in sickle cell disease.
Topics: Adult; Aldosterone; Anemia, Sickle Cell; Fludrocortisone; Humans; Hyperkalemia; Kidney; Male; Renin; | 1982 |
Hyporeninemic hypoaldosteronism associated with focal glomerular sclerosis in a patient with chronic lymphocytic leukemia.
Topics: Aged; Aldosterone; Fludrocortisone; Furosemide; Glomerulonephritis; Glomerulosclerosis, Focal Segmen | 1982 |
Glucose-induced hyperkalemia developing in the upright position in captopril-treated hypertensives.
Topics: Adolescent; Adult; Aged; Aldosterone; Captopril; Diabetes Mellitus; Female; Glucose; Glucose Toleran | 1982 |
A role for the upright posture in the development of glucose-induced hyperkalemia; prevention by a mineralocorticoid.
Topics: Aldosterone; Desoxycorticosterone; Glucose; Humans; Hyperkalemia; Insulin; Posture | 1982 |
Hyperkalemia and renal insufficiency: role of selective aldosterone deficiency and tubular unresponsiveness to aldosterone.
Topics: Aldosterone; Glomerular Filtration Rate; Humans; Hydrocortisone; Hyperkalemia; Kidney Diseases; Kidn | 1981 |
[21-hydroxylase deficit revealed by hyperkalemia in the absence of renal failure in an insulin-dependent diabetic (author's transl)].
Topics: Adrenal Hyperplasia, Congenital; Adult; Aldosterone; Diabetes Mellitus, Type 1; Female; Humans; Hype | 1981 |
Effects of amiloride on oral glucose loading, serum potassium, renin, and aldosterone in diet-controlled diabetes.
Topics: Aldosterone; Amiloride; Blood Glucose; Blood Pressure; Diabetes Mellitus; Diet, Diabetic; Glucose To | 1980 |
Hyperkalemia and hyporeninemic hypoaldosteronism.
Topics: Aged; Aldosterone; Desoxycorticosterone; Diabetes Complications; Diabetes Mellitus; Diagnosis, Diffe | 1980 |
Prevalence, pathogenesis, and functional significance of aldosterone deficiency in hyperkalemic patients with chronic renal insufficiency.
Topics: Adult; Aged; Aldosterone; Chronic Disease; Diet, Sodium-Restricted; Female; Humans; Hyperkalemia; Ki | 1980 |
[Hyporeninemic hypoaldosteronism syndrome caused by indomethacin].
Topics: Adolescent; Adult; Aldosterone; Chronic Disease; Female; Glomerulonephritis; Humans; Hyperkalemia; I | 1980 |
Etiological considerations in Gordon's syndrome: possible role of prostaglandins.
Topics: Acidosis; Aldosterone; Bradykinin; Humans; Hyperkalemia; Hypertension; Kidney; Prostaglandins; Prost | 1980 |
Induction of renin release by exogenous prostaglandins in hyporeninemic hypoaldosteronism.
Topics: Aldosterone; Blood Pressure; Diabetes Mellitus; Female; Furosemide; Humans; Hydronephrosis; Hyperkal | 1980 |
Hyperkalemia resulting from captopril administration.
Topics: Aldosterone; Captopril; Humans; Hyperkalemia; Hypertension; Hyponatremia; Male; Middle Aged; Mineral | 1980 |
Pseudohypoaldosteronism.
Topics: Aldosterone; Female; Humans; Hyperkalemia; Infant; Infant, Newborn; Male; Renal Tubular Transport, I | 1980 |
[Hyporeninemic hypoaldosteronism. Case report and attempt at pathophysiological classification (author's transl)].
Topics: Adrenal Insufficiency; Aged; Aldosterone; Fludrocortisone; Humans; Hyperkalemia; Male; Renin | 1980 |
Hyporeninemic hypoaldosteronism. An overlooked cause of hyperkalemia.
Topics: Adult; Aged; Aldosterone; Female; Humans; Hyperkalemia; Kidney Failure, Chronic; Male; Middle Aged; | 1981 |
The renin-angiotensin-aldosterone system in diabetic patients with hyperkalemia.
Topics: Adult; Aged; Aldosterone; Diabetes Complications; Female; Fludrocortisone; Humans; Hyperglycemia; Hy | 1981 |
Interaction of minoxidil and captopril in the treatment of refractory hypertension.
Topics: Acidosis; Adolescent; Aldosterone; Captopril; Creatinine; Drug Interactions; Female; Humans; Hyperka | 1981 |
Hyperkalemia associated with indomethacin.
Topics: Adult; Aldosterone; Arthritis, Infectious; Humans; Hyperkalemia; Indomethacin; Kidney; Male; Potassi | 1981 |
Reversible acute renal insufficiency and hyperkalemia following indomethacin therapy.
Topics: Acute Kidney Injury; Aged; Aldosterone; Depression, Chemical; Female; Gout; Humans; Hyperkalemia; In | 1981 |
Heparin-induced hypoaldosteronism. Report of a case.
Topics: Acidosis; Adrenal Cortex; Aldosterone; Chlorides; Heparin; Humans; Hyperkalemia; Male; Middle Aged; | 1981 |
Mineralocorticoid-resistant renal hyperkalemia without salt wasting (type II pseudohypoaldosteronism): role of increased renal chloride reabsorption.
Topics: Adult; Aldosterone; Desoxycorticosterone; Fludrocortisone; Humans; Hyperkalemia; Kidney; Male; Miner | 1981 |
Renin, aldosterone and other mineralocorticoids in hyperkalemic patients with chronic renal failure showing mild azotemia.
Topics: 18-Hydroxycorticosterone; Adult; Aldosterone; Corticosterone; Desoxycorticosterone; Female; Humans; | 1981 |
Hyperkalemic hyperchloremic metabolic acidosis in sickle cell hemoglobinopathies.
Topics: Acidosis, Renal Tubular; Adult; Aged; Aldosterone; Anemia, Sickle Cell; Chlorides; Glomerular Filtra | 1982 |
Glucose-induced hyperkalemia in normaldosteronemic diabetes associated with hyperthyroidism.
Topics: Aged; Aldosterone; Blood Glucose; Diabetes Complications; Female; Glucose; Growth Hormone; Humans; H | 1981 |
Reversal of glucose-induced hyperkalemia by sodium restriction in "normaldosteronemic" diabetes mellitus.
Topics: Adult; Aged; Aldosterone; Blood Glucose; Diabetes Complications; Diet, Sodium-Restricted; Female; Gl | 1981 |
Hyperkalemia in diabetes mellitus.
Topics: Aldosterone; Diabetes Mellitus; Female; Humans; Hyperkalemia; Middle Aged; Renin | 1982 |
Hyperkalemia in a diabetic due to renal tubular unresponsiveness to aldosterone.
Topics: Aldosterone; Diabetes Mellitus; Diabetic Nephropathies; Humans; Hydrocortisone; Hyperkalemia; Kidney | 1982 |
[Hyporeninemic hypoaldosteronism due to amyloidosis].
Topics: Aged; Aldosterone; Amyloidosis; Humans; Hyperkalemia; Kidney Diseases; Kidney Glomerulus; Male; Reni | 1982 |
[A case of mild renal failure, who showed persistent hyperkalemia and hyperchloremic acidosis without aldosterone deficiency--genesis of acidosis (author's transl)].
Topics: Acidosis, Renal Tubular; Adult; Aldosterone; Chlorides; Humans; Hyperkalemia; Kidney Failure, Chroni | 1982 |
Renal tubular hyperkalemia.
Topics: Acidosis, Renal Tubular; Aldosterone; Glomerular Filtration Rate; Humans; Hyperkalemia | 1982 |
[A case for discussion: hyperkalemia in a 64-year old patient].
Topics: Aldosterone; Diabetic Nephropathies; Diagnosis, Differential; Female; Humans; Hyperkalemia; Kidney F | 1982 |
[Potassium metabolism disorders (II)].
Topics: Addison Disease; Aldosterone; Arginine; Biological Transport; Diuretics; Hematologic Diseases; Human | 1981 |
[An unusual salt-losing syndrome: pseudohypoaldosteronism. Description of a case].
Topics: Acidosis; Aldosterone; Dehydration; Humans; Hyperkalemia; Hyponatremia; Infant; Male; Metabolic Dise | 1981 |
Reversal of glucose-induced hyperkalemia by sodium restriction in normaldosteronemic diabetes: evidence for elevated mineralocorticoid threshold.
Topics: Aldosterone; Blood Glucose; Diabetes Mellitus; Diet, Sodium-Restricted; Humans; Hyperkalemia; Minera | 1981 |
Disorders of potassium homeostasis.
Topics: Adrenal Gland Diseases; Aldosterone; Alkalosis; Humans; Hyperkalemia; Hypokalemia; Kidney Tubules, D | 1981 |
The risk of pronounced hyperkalaemia after arginine infusion in the diabetic subject.
Topics: Adolescent; Adult; Aldosterone; Arginine; Blood Glucose; Blood Proteins; Diabetes Mellitus; Female; | 1981 |
Glucose-induced hyperkalemia in diabetic subjects.
Topics: Adult; Aldosterone; Aminoglutethimide; Diabetes Mellitus; Glucose; Humans; Hyperkalemia; Male; Middl | 1981 |
Hyperkalemic distal renal tubular acidosis associated with obstructive uropathy.
Topics: Acetazolamide; Acidosis, Renal Tubular; Aged; Aldosterone; Diagnosis, Differential; Glomerular Filtr | 1981 |
[Pseudo-Bartter syndrome without hypopotassemia: a case with unilateral multicystic dysplastic kidney and congenital contralateral hyronephrosis].
Topics: Aldosterone; Bartter Syndrome; Female; Furosemide; Humans; Hydronephrosis; Hyperkalemia; Hypokalemia | 1995 |
Hyperkalemia due to hyporeninemic hypoaldosteronism with liver cirrhosis and hypertension.
Topics: Aldosterone; Captopril; Furosemide; Humans; Hyperkalemia; Hypertension; Hypoaldosteronism; Liver Cir | 1993 |
Hypoaldosteronemic hyporeninemic hyperkalemia after renal transplantation.
Topics: Adult; Aldosterone; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, C | 1993 |
Treatment and prevention of hyperkalemia in end-stage renal disease.
Topics: Aldosterone; Catecholamines; Humans; Hyperkalemia; Insulin; Kidney Failure, Chronic; Parathyroid Hor | 1993 |
Defective aldosterone synthesis associated with hyperkalemic periodic paralysis.
Topics: Aldosterone; Cytochrome P-450 CYP11B2; Female; Humans; Hyperkalemia; Infant; Mixed Function Oxygenas | 1993 |
Combined effect of bicarbonate and insulin with glucose in acute therapy of hyperkalemia in end-stage renal disease patients.
Topics: Adult; Aged; Aldosterone; Bicarbonates; Blood Glucose; Drug Combinations; Epinephrine; Female; Gluco | 1996 |
Extrarenal potassium homeostasis with maximal exercise in end-stage renal disease.
Topics: Adult; Aged; Aldosterone; Female; Hemodynamics; Homeostasis; Humans; Hyperkalemia; Insulin; Kidney F | 1996 |
Pseudohypoaldosteronism with normal blood pressure.
Topics: Acidosis, Renal Tubular; Adult; Aldosterone; Bicarbonates; Blood Pressure; Chlorides; Diuretics; Fem | 1996 |
[Role of aldosterone in potassium secretion in chronic renal failure associated with hypertension (transtubular potassium gradient)].
Topics: Aldosterone; Antihypertensive Agents; Drug Resistance; Female; Humans; Hyperkalemia; Hypertension, R | 1997 |
Role of down-regulated CHIF mRNA in the pathophysiology of hyperkalemia of acute tubular necrosis.
Topics: Aldosterone; Animals; Colon; Creatinine; Down-Regulation; Electrolytes; Hyperkalemia; Intracellular | 1998 |
Disruption of the beta subunit of the epithelial Na+ channel in mice: hyperkalemia and neonatal death associated with a pseudohypoaldosteronism phenotype.
Topics: Aldosterone; Animals; Animals, Newborn; Blastocyst; Chimera; Death; Epithelial Sodium Channels; Geno | 1999 |
Adrenal insufficiency in Smith-Lemli-Opitz syndrome.
Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; Aldosterone; Dehydrocholesterols; Humans; Hydroc | 1999 |
University of Miami Division of Clinical Pharmacology therapeutic rounds: drug-induced hyperkalemia.
Topics: Adult; AIDS-Related Opportunistic Infections; Aldosterone; Anti-Infective Agents; Diagnosis, Differe | 1998 |
Hyperkalemic renal tubular acidosis.
Topics: Acidosis, Renal Tubular; Aldosterone; Chlorides; Humans; Hyperkalemia; Hypoaldosteronism; Infant; Ki | 1998 |
Renin-aldosterone in elderly patients with hyperkalaemia under anaesthesia.
Topics: Adult; Aged; Aged, 80 and over; Aging; Aldosterone; Anesthesia, General; Anesthetics, Inhalation; An | 1999 |
A case of aldosterone-producing adenoma with severe postoperative hyperkalemia.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; Female; Fludrocortisone; Humans; Hyper | 1998 |
Hyperkalemia in patients infected with the human immunodeficiency virus: involvement of a systemic mechanism.
Topics: Adult; Aldosterone; Arginine; Female; HIV Infections; Humans; Hyperkalemia; Injections, Intravenous; | 1999 |
[Hyperkalemic periodic muscle paralysis in primary adrenocortical insufficiency. A case report].
Topics: Acidosis; Adrenal Insufficiency; Adrenocorticotropic Hormone; Adult; Aldosterone; Anti-Inflammatory | 1999 |
Fludrocortisone for the treatment of heparin-induced hyperkalemia.
Topics: Adult; Aldosterone; Anticoagulants; Creatinine; Drug Combinations; Fludrocortisone; Heparin; Humans; | 2000 |
[Biological factors influencing response to diuretics in patients with cirrhosis and ascites].
Topics: Aldosterone; Ascites; Diuretics; Female; Furosemide; Glomerular Filtration Rate; Humans; Hyperkalemi | 2001 |
Missense mutations cluster within the carboxyl-terminal region of DAX-1 and impair transcriptional repression.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Insufficiency; Adrenocorticotropic Hormone; Aldosterone; Cell | 2001 |
Trans-tubular potassium gradient in patients with drug-induced hyperkalemia.
Topics: Aged; Aged, 80 and over; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Creatinin | 2001 |
Hyperkalemia, renal failure, and converting-enzyme inhibition: an overrated connection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; A | 2001 |
Exercise-induced hyperkalemia in hypothyroid dogs.
Topics: Aldosterone; Animals; Creatine Kinase; Dog Diseases; Dogs; Female; Homeostasis; Hyperkalemia; Hypoth | 2002 |
Role of hyperkalemia in the metabolic acidosis of isolated hypoaldosteronism.
Topics: Acidosis; Aldosterone; Ammonia; Humans; Hydrogen-Ion Concentration; Hyperkalemia; Ion Exchange Resin | 1976 |
Impaired renal H+ secretion and NH3 production in mineralocorticoid-deficient glucocorticoid-replete dogs.
Topics: Acidosis; Aldosterone; Ammonia; Animals; Bicarbonates; Biological Transport; Blood; Dogs; Female; Gl | 1977 |
Renal tubular acidosis.
Topics: Acidosis, Renal Tubular; Adult; Aldosterone; Ammonia; Bicarbonates; Electrolytes; Extracellular Spac | 1977 |
Factors influencing the formation of urinary carbon dioxide tension.
Topics: Aldosterone; Animals; Bicarbonates; Carbon Dioxide; Constriction; Dogs; Female; Glomerular Filtratio | 1977 |
Renin aldosterone system and potassium levels in chronic lead intoxication.
Topics: Adult; Aged; Aldosterone; Chronic Disease; Creatinine; Edetic Acid; Female; Furosemide; Humans; Hype | 1979 |
Big renin and biosynthetic defect of aldosterone in diabetes mellitus.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Aged; Aldosterone; Blood Glucose; Corticosterone; Diabe | 1976 |
Hyperkalemia unresponsive to massive doses of aldosterone and renal tubular acidosis in a patient with chronic interstitial nephritis: clinical and experimental studies.
Topics: Acidosis, Renal Tubular; Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Chronic Disease; | 1976 |
Hyperkalemia due to selective hypoaldosteronism.
Topics: Acidosis; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Chlorides; Humans; Hyperkalemia; | 1977 |
Effect of pharmacological doses of aldosterone on the hyperosmolality-induced hyperkalemia.
Topics: Adrenocorticotropic Hormone; Aldosterone; Humans; Hydrocortisone; Hyperkalemia; Kinetics; Male; Midd | 1977 |
"Outpatient hyperkalemia" syndrome in renal and hypertensive patients with suppressed aldosterone production.
Topics: Adult; Aged; Aldosterone; Diet, Sodium-Restricted; Female; Humans; Hyperkalemia; Hypertension; Kidne | 1979 |
Hyporeninemic hypoaldosteronism after renal transplantation.
Topics: Acidosis; Aldosterone; Chlorides; Glucocorticoids; Graft Rejection; Humans; Hydrocortisone; Hyperkal | 1977 |
Investigations into the mechanisms of hyperkalemia following renal transplantation.
Topics: Adolescent; Adult; Aldosterone; Female; Humans; Hydrochlorothiazide; Hyperkalemia; Kidney Transplant | 1977 |
Transient hypoaldosteronism after renal allotransplantation.
Topics: Adult; Aldosterone; Creatinine; Humans; Hyperkalemia; Kidney Transplantation; Male; Postoperative Co | 1979 |
Increase of serum potassium in the upright posture in selective hypoaldosteronism.
Topics: Adolescent; Adult; Aldosterone; Bicarbonates; Chlorides; Glomerulonephritis; Humans; Hyperkalemia; M | 1979 |
Indomethacin-induced prostaglandin inhibition with hyperkalemia. A reversible cause of hyporeninemic hypoaldosteronism.
Topics: Adult; Aldosterone; Female; Glomerulonephritis; Humans; Hyperkalemia; Indomethacin; Potassium; Prost | 1979 |
Regulations of plasma aldosterone in young hyperkalemic patients with stable chronic renal failure.
Topics: Adolescent; Adult; Aldosterone; Diet, Sodium-Restricted; Humans; Hyperkalemia; Kidney Failure, Chron | 1979 |
Potassium: aldosterone relationships in pregnant ewes and chronically cannulated ovine fetuses.
Topics: Aldosterone; Animals; Female; Fetal Blood; Fetal Diseases; Hyperkalemia; Placenta; Potassium Chlorid | 1979 |
Indomethacin-induced inhibition of prostaglandin with hyperkalemia.
Topics: Aged; Aldosterone; Female; Humans; Hyperkalemia; Indomethacin; Kidney Function Tests; Loop of Henle; | 1979 |
Indomethacin-induced inhibition of prostaglandin with hyperkalemia.
Topics: Aldosterone; Humans; Hyperkalemia; Ibuprofen; Indomethacin; Kidney; Male; Mineralocorticoid Receptor | 1979 |
Hypertension and hyperkalaemia responding to bendrofluazide.
Topics: Adult; Aldosterone; Arginine Vasopressin; Bendroflumethiazide; Diet, Sodium-Restricted; Furosemide; | 1979 |
Syndrome of hyporeninemic hypoaldosteronism. Study of two cases and review of the literature.
Topics: Aldosterone; Cryoglobulins; Heart Failure; Humans; Hyperkalemia; Immunoglobulin G; Immunoglobulin M; | 1977 |
[Hyperkalemic, hyperchloremic acidosis in moderate chronic renal insufficiency and selective hypoaldosteronism].
Topics: Acidosis; Adult; Aged; Aldosterone; Chlorides; Female; Humans; Hyperkalemia; Hypertension; Kidney Fa | 1977 |
[Hyperkalemia caused by hyporeninism: role of the hydrochlorothiazide-amiloride combination].
Topics: Aged; Aldosterone; Amiloride; Diabetes Complications; Female; Heart Failure; Humans; Hydrochlorothia | 1977 |
Familial hyperkalemia, hypertension, and hyporeninemia with normal aldosterone levels. A tubular defect in potassium handling.
Topics: Acidosis; Adrenal Glands; Aldosterone; Humans; Hyperkalemia; Hypertension; Kidney; Male; Middle Aged | 1978 |
Glucose-induced hyperkalemia with normal aldosterone levels. Studies in a patient with diabetes mellitus.
Topics: Aged; Aldosterone; Desoxycorticosterone; Diabetes Mellitus; Glucose; Humans; Hyperkalemia; Insulin; | 1978 |
Regulation of plasma aldosterone by glucose-induced paradoxical hyperkalemia in the presence of suppressed renin-angiotensin system.
Topics: Adult; Aldosterone; Angiotensin II; Blood Chemical Analysis; Glucose; Humans; Hyperkalemia; Kinetics | 1978 |
Unexplained hyperkalemia may signal renin-aldosterone defect.
Topics: Aldosterone; Female; Humans; Hyperkalemia; Male; Middle Aged; Renin; Syndrome | 1978 |
[Case of isolated aldosterone deficiency].
Topics: Aged; Aldosterone; Female; Humans; Hyperkalemia; Renin | 1978 |
Distal renal tubular acidosis in selective hypoaldosteronism.
Topics: Acidosis, Renal Tubular; Aged; Aldosterone; Electrophysiology; Fludrocortisone; Humans; Hydrogen; Hy | 1978 |
Familial hyperpotassemia and hypertension accompanied by normal plasma aldosterone levels: possible hereditary cell membrane defect.
Topics: Adult; Aldosterone; Cell Membrane; Humans; Hyperkalemia; Hypertension; Insulin; Kidney Function Test | 1978 |
Proximal renal tubular acidosis: association with familial normaldosteronemic hyperpotassemia and hypertension.
Topics: Acidosis, Renal Tubular; Adult; Aldosterone; Child; Child, Preschool; Female; Humans; Hyperkalemia; | 1978 |
Impaired renal tubular potassium secretion in systemic lupus erythematosus.
Topics: Acetazolamide; Adult; Aldosterone; Female; Fludrocortisone; Furosemide; Humans; Hyperkalemia; Kidney | 1977 |
Hyporeninemia and hypoaldosteronism in diabetes mellitus.
Topics: Adult; Aldosterone; Blood Pressure; Diabetes Complications; Diabetes Mellitus; Female; Humans; Hyper | 1977 |
Nonuremic diabetic hyperkalemia. Possible role of insulin deficiency.
Topics: Aldosterone; Diabetes Complications; Humans; Hyperkalemia; Insulin; Potassium; Renin | 1977 |
Postural plasma aldosterone response in "upright hyperkalemia" associated with selective hypoaldosteronism.
Topics: Adult; Aged; Aldosterone; Diet, Sodium-Restricted; Humans; Hyperkalemia; Male; Posture | 1977 |
Effect of mineralocorticoids on the paradoxical glucose-induced hyperkalemia in nondiabetic patients with selective hypoaldosteronism.
Topics: Aldosterone; Blood Glucose; Glomerulonephritis; Glucose; Humans; Hyperkalemia; Insulin; Mineralocort | 1977 |
[Physiopathogenetic, clinical and therapeutic considerations on pseudohypoaldosteronism. Apropos of 3 personal cases, compared with the world-wide cases].
Topics: Adrenal Cortex Function Tests; Adrenal Insufficiency; Adult; Aged; Aldosterone; Angiotensin II; Diet | 1977 |
Pseudohypoaldosteronism due to sweat gland dysfunction.
Topics: Aldosterone; Child, Preschool; Dehydration; Female; Humans; Hyperkalemia; Hyponatremia; Kidney; Pota | 1976 |
Hyporeninemic hypoaldosteronism after chronic sodium bicarbonate abuse.
Topics: Aldosterone; Bicarbonates; Dose-Response Relationship, Drug; Dyspnea; Humans; Hyperkalemia; Hyponatr | 1976 |
Hyperkalemia unresponsive to massive doses of aldosterone in a patient with renal tubular acidosis.
Topics: Acidosis, Renal Tubular; Aldosterone; Drug Resistance; Humans; Hyperkalemia; Kidney Tubules; Male; M | 1976 |
Clinicopathological conference. A case of hypoaldosteronism.
Topics: Adenoma; Adrenal Insufficiency; Aldosterone; Bone Neoplasms; Chondroma; Female; Humans; Hyperkalemia | 1975 |
Paradoxical glucose-induced hyperkalemia. Combined aldosterone-insulin deficiency.
Topics: Aldosterone; Desoxycorticosterone; Diabetes Complications; Diabetes Mellitus; Humans; Hyperglycemia; | 1975 |
Water, sodium, potassium, and electrolyte balance.
Topics: Aged; Aldosterone; Child, Preschool; Diet; Diet, Sodium-Restricted; Humans; Hyperaldosteronism; Hype | 1975 |
Editorial: Aldosterone, potassium and acidosis.
Topics: Acidosis; Aldosterone; Ammonia; Humans; Hyperkalemia; Renin | 1976 |
Pathologic hypofunction of the renin-angiotensin-aldosterone system.
Topics: Adrenal Insufficiency; Adult; Aged; Aldosterone; Angiotensin II; Diagnosis, Differential; Female; Hu | 1976 |
[Primary aldosteronism].
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Hyperfunction; Aldosterone; Antihyp | 1976 |
Letter: Hyperkalemia in hypoaldosteronism.
Topics: Aldosterone; Ammonia; Humans; Hyperkalemia; Kidney | 1976 |
[Diagnosis and treatment of primary aldosteronism].
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hyperkalem | 1992 |
Dose dependent suppression of mineralocorticoid metabolism by different heparin fractions.
Topics: Adult; Aldosterone; Depression, Chemical; Dose-Response Relationship, Drug; Female; Heparin; Heparin | 1992 |
Effect of atrial natriuretic peptide on potassium-stimulated aldosterone secretion: potential relevance to hypoaldosteronism in man.
Topics: Adult; Aldosterone; Atrial Natriuretic Factor; Humans; Hyperkalemia; Hypoaldosteronism; Infusions, I | 1992 |
On the mechanism of impaired distal acidification in hyperkalemic renal tubular acidosis: evaluation with amiloride and bumetanide.
Topics: Acidosis, Renal Tubular; Aldosterone; Amiloride; Bumetanide; Humans; Hydrogen; Hydrogen-Ion Concentr | 1992 |
Heterogeneous changes of serum potassium levels in NIDDM patients on oral glucose load.
Topics: Administration, Oral; Adult; Aldosterone; Diabetes Mellitus, Type 2; Female; Glucose; Glucose Tolera | 1992 |
Endocrine sodium and volume regulation in familial hyperkalemia with hypertension.
Topics: Adult; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Family; Female; Humans; Hydrochloroth | 1992 |
Severe tubular resistance to aldosterone in a child with familial juvenile nephronophthisis.
Topics: Aldosterone; Child; Female; Humans; Hyperkalemia; Kidney Diseases, Cystic; Kidney Function Tests; Ki | 1992 |
Extrarenal potassium tolerance in chronic renal failure: implications for the treatment of acute hyperkalemia.
Topics: Acute Disease; Adrenal Glands; Aldosterone; Epinephrine; Humans; Hyperkalemia; Kidney Failure, Chron | 1992 |
Corticosterone methyl oxidase type II deficiency: a cause of failure to thrive and recurrent dehydration in early infancy.
Topics: 18-Hydroxycorticosterone; Aldosterone; Cytochrome P-450 CYP11B2; Dehydration; Diagnosis, Differentia | 1992 |
Hyperkalemia in very low birth weight infants.
Topics: Aldosterone; Humans; Hyperkalemia; Incidence; Infant, Low Birth Weight; Infant, Newborn; Potassium; | 1992 |
The syndrome of hypertension and hyperkalemia with normal GFR (Gordon's syndrome): is there increased proximal sodium reabsorption?
Topics: Absorption; Adult; Aldosterone; Atrial Natriuretic Factor; Female; Glomerular Filtration Rate; Human | 1991 |
[Abnormal production of adrenal gland hormones--special reference to mineralocorticoids].
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aged; Aldosterone; Calcium Channel Blockers; Dexameth | 1991 |
Hyperkalaemia induced by carbonic anhydrase inhibitor.
Topics: Acidosis; Acute Kidney Injury; Aged; Aged, 80 and over; Aldosterone; Dichlorphenamide; Glaucoma; Hum | 1991 |
Hyperkalemia and hypertension: is this a "chloride-shunt" disorder?
Topics: Acidosis; Adolescent; Aldosterone; Chlorides; Diuretics; Female; Humans; Hyperkalemia; Hypertension; | 1990 |
Increased sodium requirement following early postnatal surgical correction of congenital uropathies in infants.
Topics: Aldosterone; Humans; Hyperkalemia; Hyponatremia; Infant; Infant, Newborn; Kidney Tubules; Potassium; | 1990 |
Acquired partial corticosterone methyl oxidase type II defect in diabetes mellitus. Case of hyperreninemic hypoaldosteronism.
Topics: 18-Hydroxycorticosterone; Adrenocorticotropic Hormone; Aged; Aldosterone; Cytochrome P-450 CYP11B2; | 1990 |
Heparin-induced hyperkalemia.
Topics: Adult; Aldosterone; Female; Heparin; Humans; Hyperkalemia; Hypoaldosteronism; Male; Middle Aged; Pot | 1990 |
Biochemical correction in the syndrome of hypertension and hyperkalaemia by severe dietary salt restriction suggests renin-aldosterone suppression critical in pathophysiology.
Topics: Adult; Aldosterone; Angiotensin II; Animals; Diet, Sodium-Restricted; Family Health; Humans; Hyperka | 1990 |
Hyperkalemia in the elderly.
Topics: Adrenal Cortex; Aged; Aging; Aldosterone; Combined Modality Therapy; Humans; Hyperkalemia; Hypoaldos | 1990 |
Unusual association of hyperkalemia and hypertension.
Topics: Adult; Aldosterone; Bicarbonates; Erythrocytes; Female; Humans; Hyperkalemia; Hypertension; Ion Chan | 1986 |
[Physiopathology and clinical aspects of type IV renal tubular acidosis].
Topics: Acidosis, Renal Tubular; Aldosterone; Humans; Hyperkalemia; Ion Channels; Kidney Tubules, Distal; Po | 1987 |
[Pseudohypoaldosteronism--renal salt loss syndrome. Therapy and course exemplified by 2 siblings].
Topics: Acidosis; Aldosterone; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Hyperkalemia; Hyp | 1986 |
Generalized unresponsiveness to mineralocorticoid hormones: familial recessive pseudohypoaldosteronism due to aldosterone-receptor deficiency.
Topics: Aldosterone; Consanguinity; Drug Resistance; Feces; Female; Humans; Hyperkalemia; Hyponatremia; Infa | 1986 |
[Arterial hypertension with hyperkalemia, tubular acidosis and normal renal function: Gordon syndrome and/or pseudohypoaldosteronism type II?].
Topics: Acidosis, Renal Tubular; Aldosterone; Atrial Natriuretic Factor; Humans; Hyperkalemia; Hypertension; | 1988 |
A new Australian kindred with the syndrome of hypertension and hyperkalaemia has dysregulation of atrial natriuretic factor.
Topics: Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Australia; Fludrocortisone; Humans; Hyperkal | 1988 |
Inadequate aldosterone response to hyperkalemia during angiotensin converting enzyme inhibition in chronic renal failure.
Topics: Adolescent; Adult; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Child; Creatini | 1985 |
Selective hypoaldosteronism due to an endogenous impairment in angiotensin II production.
Topics: Acidosis; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Female; Humans; Hyperkalemia; Hypo | 1987 |
Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure.
Topics: Adult; Aged; Aldosterone; Bicarbonates; Blood Glucose; Epinephrine; Female; Humans; Hyperkalemia; In | 1988 |
Successful treatment of hyperkalemic quadriplegia associated with spironolactone.
Topics: Acid-Base Equilibrium; Aged; Aldosterone; Blood Glucose; Electrocardiography; Electrolytes; Female; | 1988 |
Effect of selective aldosterone deficiency on acidification in nephron segments of the rat inner medulla.
Topics: Acid-Base Equilibrium; Acidosis; Aldosterone; Ammonia; Animals; Bicarbonates; Chlorides; Dexamethaso | 1988 |
Mechanisms of hyperkalemia in systemic lupus erythematosus.
Topics: Adult; Aldosterone; Angiotensin I; Bicarbonates; Captopril; Chlorides; Enzyme Precursors; Female; Fu | 1988 |
Blunted kaliuresis after an acute oral potassium load in diabetes mellitus.
Topics: Adult; Aldosterone; Creatinine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 1 | 1988 |
[Hyperkalemia and hyperchloremia in metabolic acidosis].
Topics: Acidosis, Renal Tubular; Adult; Aged; Aldosterone; Chlorides; Female; Humans; Hyperkalemia; Male; Re | 1987 |
Suppression of plasma renin activity in a boy with chronic hyperkalemia.
Topics: Acidosis; Adolescent; Aldosterone; Body Height; Chronic Disease; Humans; Hyperkalemia; Male; Puberty | 1987 |
Interplay of various factors in glucose-induced hyperkalemia during captopril treatment.
Topics: Adult; Aldosterone; Blood Glucose; Blood Pressure; Captopril; Glomerular Filtration Rate; Glucose; G | 1986 |
Evidence of prostacyclin deficiency in the syndrome of hyporeninemic hypoaldosteronism.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Aldosterone; Blood Pressure; Calcium; Epoprostenol; Femal | 1986 |
Hyporeninemic hypoaldosteronism.
Topics: Aldosterone; Epoprostenol; Humans; Hyperkalemia; Renin; Syndrome | 1986 |
[Progressive hyperkalemia during chronic captopril therapy (pharmacological hypoaldosteronism)].
Topics: Aged; Aldosterone; Captopril; Dose-Response Relationship, Drug; Humans; Hyperkalemia; Hypertension; | 1986 |
Isolated hypoaldosteronism and abnormalities in renin, kallikrein, and prostaglandin.
Topics: Adult; Aged; Aldosterone; Dinoprostone; Humans; Hyperkalemia; Kallikreins; Male; Middle Aged; Prosta | 1986 |
The syndrome of hypertension and hyperkalaemia with normal GFR. A unique pathophysiological mechanism for hypertension?
Topics: Adult; Aldosterone; Diet; Female; Glomerular Filtration Rate; Humans; Hyperkalemia; Hypertension; Ki | 1986 |
[A case of normotensive hypokalemia similar to Liddle's syndrome with episodic and paroxysmal hyperkalemia].
Topics: Adult; Aldosterone; Female; Humans; Hyperkalemia; Hypokalemia; Periodicity; Potassium; Renin; Sodium | 1986 |
Mineralocorticoid-induced kaliuresis in type-II pseudohypoaldosteronism.
Topics: Acidosis; Adult; Aldosterone; Benzothiadiazines; Desoxycorticosterone; Diuretics; Humans; Hyperkalem | 1986 |
Prostaglandin excretion in pseudohypoaldosteronism type I.
Topics: Aldosterone; Dinoprost; Dinoprostone; Humans; Hyperkalemia; Hyponatremia; Infant; Male; Prostaglandi | 1986 |
Systemic lupus erythematosus presenting with hyporeninemic hypoaldosteronism in a 10-year-old girl.
Topics: Aldosterone; Child; Female; Humans; Hyperkalemia; Lupus Erythematosus, Systemic; Lupus Nephritis; Re | 1986 |
Hyperkalaemia secondary to hypo-aldosteronism. A report of 2 cases differentiating hyperreninaemic from hyporeninaemic hypo-aldosteronism.
Topics: Aldosterone; Female; Humans; Hydrocortisone; Hyperkalemia; Male; Middle Aged; Renin | 1987 |
Hyperkalemic left bundle branch block and hyporeninemic hypoaldosteronism (hyperkalemic left bundle branch block).
Topics: Aged; Aldosterone; Bundle-Branch Block; Diagnosis, Differential; Female; Humans; Hyperkalemia; Kidne | 1986 |
Early childhood hyperkalemia: variety of pseudohypoaldosteronism.
Topics: Aldosterone; Bicarbonates; Electrolytes; Female; Humans; Hyperkalemia; Infant; Infant, Newborn; Male | 1986 |
Hypertension, mineralocorticoid-resistant hyperkalemia, and hyperchloremic acidosis in an infant with obstructive uropathy.
Topics: Acid-Base Equilibrium; Acidosis, Renal Tubular; Aldosterone; Chlorides; Drug Resistance; Humans; Hyd | 1986 |
Effect of dopaminergic blockade on plasma aldosterone in acquired hypoaldosteronism.
Topics: Adult; Aldosterone; Dopamine Antagonists; Humans; Hyperkalemia; Hypoaldosteronism; Kidney Failure, C | 1987 |
Pseudohypoaldosteronism type II: proximal renal tubular acidosis and dDAVP-sensitive renal hyperkalemia.
Topics: Acid-Base Equilibrium; Acidosis, Renal Tubular; Adult; Aldosterone; Deamino Arginine Vasopressin; Dr | 1986 |
Effects of cyclosporine on the renin-angiotensin-aldosterone system and potassium excretion in renal transplant recipients.
Topics: Adult; Aldosterone; Azathioprine; Cyclosporins; Humans; Hyperkalemia; Kidney Transplantation; Middle | 1985 |
Familiar hyperkalaemic acidosis.
Topics: Acid-Base Equilibrium; Acidosis, Renal Tubular; Adult; Aldosterone; Desoxycorticosterone; Diet, Sodi | 1985 |
Hyporeninemic hypoaldosteronism. New associations.
Topics: Aldosterone; Electrolytes; Humans; Hyperkalemia; Male; Middle Aged; Pancreatectomy; Pancreatic Disea | 1985 |
[Review on internal medicine, 1984. Electrolyte disturbance. II-3. Hyperkalemia in hyporeninemic hypoaldosteronism].
Topics: Adult; Aged; Aldosterone; Animals; Humans; Hyperkalemia; Middle Aged; Potassium; Rats; Renin | 1985 |
Hyperkalemic distal renal tubular acidosis and selective aldosterone deficiency. Combination in a patient with lead nephropathy.
Topics: Acetazolamide; Acidosis, Renal Tubular; Aldosterone; Electrolytes; Female; Fludrocortisone; Furosemi | 1985 |
[Type II pseudohypoaldosteronism: proximal tubular acidosis and distal tubular hyperkalemia corrected by DDAVP].
Topics: Acidosis, Renal Tubular; Adult; Aldosterone; Deamino Arginine Vasopressin; Humans; Hyperkalemia; Mal | 1985 |
[Pseudohypoaldosteronism associated with chronic interstitial nephropathy].
Topics: Aldosterone; Female; Humans; Hyperkalemia; Hyponatremia; Kidney Failure, Chronic; Middle Aged; Nephr | 1985 |
Salt wasting, raised plasma-renin activity, and normal or high plasma-aldosterone: a form of pseudohypoaldosteronism.
Topics: Acidosis; Aldosterone; Bicarbonates; Blood Urea Nitrogen; Carbon Dioxide; Child; Child, Preschool; D | 1973 |
Partial 3 -hydroxysteroid dehydrogenase (3 -HSD) deficiency in a family with congenital adrenal hyperplasia: evidence for increasing 3 -HSD activity with age.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Gland Diseases; Aging; Aldosterone; Androstanes; | 1971 |
Familial aldosterone deficiency: enzyme defect, diagnosis, and clinical course.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Aldosterone; Chromatography; Desoxycorticoster | 1968 |
Aldosterone deficiency in chronic renal failure.
Topics: Adrenal Insufficiency; Aged; Aldosterone; Angiotensin II; Diet; Fludrocortisone; Humans; Hyperkalemi | 1968 |
Primary periodic paralysis associated with hyperkalemic and hypokalemic attacks and with hemolytic bilirubinemia.
Topics: Acetazolamide; Adolescent; Adrenocorticotropic Hormone; Adult; Aldosterone; Bilirubin; Dexamethasone | 1968 |
[Secondary hyperaldosteronisms].
Topics: Aldosterone; Angiotensin II; Heart Failure; Hyperaldosteronism; Hyperkalemia; Hypertension, Malignan | 1969 |
Selective hypoaldosteronism with hyperkalemia.
Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Body Weight; Desoxy | 1972 |
Control of deoxycorticosterone secretion in the dog.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Catheterization; | 1972 |
Isolated hypoaldosteronism in adults. A renin-deficiency syndrome.
Topics: 17-Hydroxycorticosteroids; Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Angiotensin II; Di | 1972 |
Recurrent hyperkalaemia due to selective aldosterone deficiency: correction by angiotensin infusion.
Topics: Adrenal Glands; Adrenal Insufficiency; Aged; Aldosterone; Angiotensin II; Autopsy; Diet Therapy; Fem | 1973 |
Syndrome of hyporeninemic hypoaldosteronism and hyperkalemia in renal disease.
Topics: 17-Hydroxycorticosteroids; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aged; Aging; Aldoster | 1973 |
Steroid excretion by an infant with an unusual salt-losing syndrome: a gas chromatographic-mass spectrometric study.
Topics: Aldosterone; Androstenols; Chromatography, Gas; Corticosterone; Cortisone; Desoxycorticosterone; Flu | 1974 |
[A new method of treatment of hereditary episodic adynamia (Gamstorp's disease) (author's transl)].
Topics: Administration, Oral; Aldosterone; Calcium; Chlorine; Corticosterone; Humans; Hyperkalemia; Ion Exch | 1974 |
Renal acidosis and renal potassium handling in selective hypoaldosteronism.
Topics: Acidosis, Renal Tubular; Adrenal Insufficiency; Aldosterone; Bicarbonates; Calcium Chloride; Desoxyc | 1974 |
[Hyporeninic hypoaldosteronism: pathogenetic importance of kidney parenchyma diseases and age].
Topics: Adult; Age Factors; Aged; Aldosterone; Humans; Hyperkalemia; Kidney Failure, Chronic; Middle Aged; P | 1974 |
Management of potassium problems during long-term diuretic therapy.
Topics: Aldosterone; Diet; Diuretics; Extracellular Space; Homeostasis; Humans; Hydrogen-Ion Concentration; | 1974 |
Selective hypoaldosteronism: a case report and review of literature.
Topics: Adrenal Insufficiency; Adult; Aldosterone; Diabetes Complications; Heart Diseases; Humans; Hyperkale | 1974 |
Plasma aldosterone in terminal renal failure.
Topics: Acute Kidney Injury; Aldosterone; Diet; Humans; Hyperkalemia; Hypertension, Renal; Hypokalemia; Neph | 1973 |
Hyperkalemia in salt-wasting nephropathy. Study of the mechanism.
Topics: Aldosterone; Bicarbonates; Desoxycorticosterone; Furosemide; Glomerular Filtration Rate; Glucose; Hu | 1973 |
Impaired renin responsiveness with secondary hypoaldosteronism.
Topics: Adrenal Glands; Adrenal Insufficiency; Aldosterone; Arrhythmias, Cardiac; Body Weight; Creatinine; D | 1973 |
Clinical use of potassium supplements and potassium sparing diuretics.
Topics: Aldosterone; Amiloride; Diuretics; Drug Therapy, Combination; Humans; Hyperkalemia; Hypokalemia; Kid | 1973 |
[Anephric man].
Topics: Aldosterone; Animals; Arteries; Blood Glucose; Body Weight; Diet Therapy; Dogs; Erythropoiesis; Hema | 1968 |
Hyperkalemic intermittent paralysis associated with spironolactone in a patient with cardiac cirrhosis.
Topics: Acetazolamide; Adult; Aldosterone; Ascites; Female; Furosemide; Heart Failure; Heart Valve Diseases; | 1968 |
Hyperkalemia and coma associated with renal tubular acidosis in an old patient with refractory edema due to the nephrotic syndrome: furosemide-bicarbonate therapy.
Topics: Acidosis, Renal Tubular; Adrenal Cortex Hormones; Aged; Aldosterone; Bicarbonates; Coma; Edema; Furo | 1972 |
Hyperkalemia and renin deficiency.
Topics: Aldosterone; Humans; Hyperkalemia; Kidney Diseases; Metabolism, Inborn Errors; Potassium; Renin; Sod | 1972 |
Hyperkalemia and renin production.
Topics: Aldosterone; Humans; Hyperkalemia; Potassium; Renin | 1972 |
[Primary aldosteronism without association of hypokalemia].
Topics: 17-Hydroxycorticosteroids; Aldosterone; Blood Pressure; Humans; Hyperaldosteronism; Hyperkalemia; Hy | 1969 |
[Diagnosis and therapy of the salt-losing syndrome].
Topics: Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Aldosterone; Deficiency Diseases; Desoxycort | 1969 |
Plasma electrolyte concentrations and steroid secretion in the bullfrog and opossum.
Topics: Aldosterone; Animals; Anura; Corticosterone; Dexamethasone; Glucose; Hyperkalemia; Hyponatremia; Opo | 1970 |
Hypertension and severe hyperkalaemia associated with suppression of renin and aldosterone and completely reversed by dietary sodium restriction.
Topics: Aldosterone; Ammonia; Bicarbonates; Blood Urea Nitrogen; Child; Chlorides; Creatinine; Diet, Sodium- | 1970 |
Selective aldosterone deficiency in chronic pyelonephritis.
Topics: Aged; Aldosterone; Blood Urea Nitrogen; Chronic Disease; Female; Fludrocortisone; Humans; Hyperkalem | 1970 |
Aldosterone deficiency and renal bicarbonate reabsorption.
Topics: Acidosis; Adrenal Gland Diseases; Adrenalectomy; Aldosterone; Animals; Bicarbonates; Carbon Dioxide; | 1971 |
Electrolyte disorders.
Topics: Aldosterone; Extracellular Space; Humans; Hyperkalemia; Hypernatremia; Hyponatremia; Potassium; Preo | 1968 |
Syndrome of idiopathic hyperkalaemia and hypertension with decreased plasma renin activity: effects on plasma renin and aldosterone of reducing the serum potassium level.
Topics: Adolescent; Aldosterone; Chlorothiazide; Corticosterone; Glomerular Filtration Rate; Humans; Hydroco | 1968 |
Selective aldosterone deficiency.
Topics: 17-Ketosteroids; Adolescent; Adrenal Insufficiency; Aged; Aldosterone; Aminohippuric Acids; Carbon I | 1969 |
Inhibition of aldosterone secretion by ouabain in dog adrenal cortical tissue.
Topics: 17-Hydroxycorticosteroids; Adrenal Glands; Aldosterone; Animals; Corticosterone; Depression, Chemica | 1969 |
[Long term development of adrenal gland insufficiency, designated regressive, in newborn infants].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Cortex Hormones; Adrenal Insufficiency; Aldoster | 1969 |
Pathogenesis of hyperkalemia in hypoaldosteronism.
Topics: Adrenal Insufficiency; Adrenalectomy; Aldosterone; Blood Urea Nitrogen; Desoxycorticosterone; Fludro | 1969 |
Pathogenesis of hyperkalemia in hypoaldosteronism.
Topics: Adolescent; Adrenal Insufficiency; Adrenalectomy; Aged; Aldosterone; Blood Urea Nitrogen; Desoxycort | 1969 |